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ABSTRACT 
DEVELOPMENT OF DNA ASSEMBLY AND ERROR CORRECTION PROTOCOLS 
FOR A DIGITAL MICROFLUIDIC DEVICE 
by Yuliya Khilko 
Customized production of synthetic DNA from oligonucleotides is in high demand.  
However, current technologies are costly and labor-intensive.  A microfluidic technology 
can significantly decrease cost and labor.  The purpose of this study was to develop a 
gene assembly protocol that was utilized on the Mondrian™ SP digital microfluidic 
device.  The fragment of the human influenza virus hemagglutinin (HA) gene (339 bp) 
was assembled from 12 oligonucleotides by the Gibson assembly method and error 
corrected with CorrectASE™ enzyme twice.  The samples were analyzed by Sanger 
sequencing to verify the final accuracy of the assembly.  A complete automation of 
droplet generation and movement on digital microfluidic droplet technology was 
achieved in the study.  The reactions were scaled down to 0.6-1.2 µL.  Gibson assembly, 
PCR, and enzymatic error correction reactions were optimized and combined in a single 
protocol.  The microfluidic assembly demonstrated approximately 3 errors/kb error 
frequency.  Polymerase chain reaction supplemented with additional MgCl2, Phusion, and 
PEG 8000 provided amplification of the assembly and error correction products.  The 
lowest error frequency of 0.3 errors/kb was achieved after one CorrectASE™ treatment.  
However, microfluidic error correction was not reliable due to CorrectASE™ interactions 
with the microfluidic surface, which need to be the subject of future work.
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CHAPTER ONE 
INTRODUCTION 
Over the last decade, major research advances in genome sequencing (i.e. “DNA 
reading”) are slowly being matched by advances in synthetic biology (i.e. “DNA 
writing”).  Naturally occurring genomes have been modified with synthetic DNA for 
changing existing or engineering new biological pathways.  Advancements in synthetic 
genomics went beyond the scope of gene editing.  Researchers at the J. Craig Venter 
Institute (JCVI) were able to create a minimal synthetic cell.  In that work, the 
chromosome of Mycoplasma mycoides syn3.0 was synthesized from oligonucleotides and 
consisted of 531 kilobase pairs (kbp).  The minimal cell had 323 genes out of 473 that 
were identified to be essential for cell growth and survival [1].  This research opens 
opportunities to understand the functions of genes found in the human genome and to 
develop new gene editing techniques.  Additionally, synthetic genes are employed in the 
production of bio-derived chemicals and clean energy.  For example, metabolic pathways 
in cyanobacteria were modified, so they could produce 1,3-propandiol, which is the 
important intermediate of polyethylene terephthalate and nylon synthesis [2].  There is a 
demand for synthetic DNA that will only increase in the future.  However, the ability to 
synthesize long DNA molecules in a short period of time without significant expense 
remains one of the main challenges in synthetic biology.  
The next sections provide a short introduction to several concepts that important for 
understanding the background behind DNA assembly. 
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1.1 Deoxyribonucleic Acid 
Deoxyribonucleic acid (DNA) is a biological polymer with a double helix structure.  
The molecule is composed of a number of repeated nucleotides, the building blocks of 
DNA.  Deoxyribose, phosphate and a nitrogenous base (purine or pyrimidine) are the 
three main components of nucleotides.  The purines, found in DNA molecules, are 
adenine (A) and guanine (G), and pyrimidines are thymine (T) and cytosine (C).  A 
helical structure of DNA is caused by the ability to form complementary base pairs.  
Adenine forms hydrogen bonds with thymine.  Guanine pairs with cytosine [3].  A basic 
DNA structure is shown in Figure 1. 
 
 
Figure 1.  Structure of DNA. 
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1.2 Polymerase Chain Reaction 
The polymerase chain reaction (PCR) is one of the most used amplification 
techniques in molecular biology and is an essential step for DNA assembly.  The reaction 
is used to make multiple copies of a target DNA fragment.  The process is based on the 
use of a DNA polymerase, a temperature resistant enzyme, which can build a 
complementary strand.  A polymerase, a DNA template, oligonucleotide primers, buffer 
solutions, and deoxynucleotide triphosphates (dNTPs) are the necessary reagents.  The 
reaction pathway is shown in Figure 2.  First, a template (dsDNA) is separated at high 
temperature.  Then, the mixture is cooled down, which allows primers to bind.  Finally, 
the DNA polymerase extends strands by adding dNTPs.  At the end of the first cycle, two 
identical nucleic acids are produced.  In order to achieve sufficient amplification, the 
process is repeated for 25-40 times [3].   
 
Figure 2.  A description of one cycle of polymerase chain reaction. 
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1.3 Gene Assembly 
Gene assembly is a method of constructing long molecules from DNA 
oligonucleotides (oligos).  The oligonucleotides are single-stranded (ssDNA) fragments, 
which are usually 50-100 bases long.  The oligonucleotides are designed to overlap by 
20-30 bases.  Figure 3 demonstrates step by step gene assembly.  The ends of oligos are 
joined together in a series of enzymatic reactions to make larger fragments of DNA.  
These fragments of DNA can be assembled into genomes up to hundreds of kilobases 
(kb) in a hierarchical order.  Smaller molecules (several hundred base pairs) assembled 
from oligonucleotides can themselves be assembled into larger fragments (up to ~10 kb). 
Each step is followed by PCR amplification.  After ~10 kb, PCR becomes difficult, so the 
assembly of larger fragments must use a restriction enzyme.  Digested and purified 
constructs are mixed together and either joined using the Gibson assembly or by the 
assembly in yeast [4].  The obtained nucleic acids are ligated into a vector.  The vectors 
are transformed into E. coli.  In order to obtain error-free products, the DNA from a 
single colony must be sequence verified [5, 6]. 
 5 
 
 
Figure 3.  Gene assembly method.  (Reprinted by permission from Macmillan Publishers 
Ltd.: [Nature Methods] ([6]), copyright (2010). 
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1.4 Error Correction 
Genes assembled from oligonucleotides typically contain errors.  The majority of the 
errors come from oligonucleotide synthesis.  During DNA assembly, oligonucleotides are 
used as templates for a complimentary strand synthesis, and the existing errors are 
copied.  As a result, there are deletions, substitutions, and insertions in the sequence.  
Current error correction methods are based on removal of mismatches.  In order to 
recognize mismatches, DNA strands have to be separated and reannealed.  When the 
strands come together, it is unlikely that the DNA strand will come back together with a 
complementary strand containing the mismatch and non-base paired “bulges” are formed 
in the mismatch areas.  Mismatch-binding proteins and mismatch-cleavage enzymes are 
two types of error correction agents.  The mismatch-binding protein MutS recognizes and 
binds to heteroduplexes.  Next, error free sequences are separated by the mobility shift 
assay.  Unfortunately, this method is only suitable for sequences having a small amount 
of errors.  On the other hand, error removal with mismatch-cleavage enzymes is a       
one-step process.  The enzymes can recognize bulges and cut out errors [7].  
1.5 Programmable Digital Microfluidics 
Digital microfluidics (DMF) is a technology based on the electrowetting 
phenomenon.  The phenomenon describes a change of surface tension at a 
solid/liquid/gas interface by application of the electric field [8].  The change of surface 
tension under applied voltage is described by Equation 1, which was introduced by 
Lippmann.  
γ =  γ0 −
1
2
CV2                                                                                              Equation 1 
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where γ0 is the initial surface tension (N/m), C is the capacitance per unit area of 
dielectric (J/V2m2), γ is the surface tension after applied electrical field (N/m), and V is 
the voltage (V).  The voltage applied on the electrodes lowers the surface tension, which 
leads to a reduction of the contact angle and increases the wettability of the surface.  The 
reduction of the contact angle is shown in Figure 4.  Consequently, the liquid spreads 
over the surface where the voltage was applied.  Thus, a hydrophobic surface becomes 
hydrophilic.  By the application of a voltage on a dielectric surface, the liquids can be 
transported over the surface of a microfluidic cartridge [8, 9].   
  
Figure 4.  A contact angle reduction under applied electrical field. 
Figure 5 demonstrates a microfluidic cartridge operated by electrowetting on 
dielectric (EWOD).  A droplet is sandwiched between two hydrophobic plates and the 
remaining volume is filled with immiscible liquid, for example, a silicone oil.  The oil 
adds an additional layer of insulation, coats droplets to prevent evaporation, and 
facilitates transport.  The bottom plate is the array of electrodes, which can locally control 
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the surface tension.  By turning on and off the voltage on certain electrodes, the droplets 
can be directed anywhere on a chip.  They can also be split, fused, and held in certain 
regions.  The cartridge is inserted in to a machine that is operated by a software program 
[10, 11]. 
 
Figure 5.  A cross-section of an EWOD cartridge. 
1.6 Significance of Research 
Gene synthesis is a costly and labor intensive process.  The cost of synthetic DNA is 
directly related to the cost of oligonucleotides.  The cheapest oligos that can be purchased 
from commercial suppliers are usually unpurified and contain errors.  Thus, the genes, 
assembled from the unpurified oligos, have to be sequence verified to find a correct 
assembly.  Typically, tedious molecular biology operations are performed to assemble 
DNA in recombinant plasmids and to clone them in bacterial cells.  The plasmids are 
isolated from bacterial cultures and Sanger sequenced.  It can take from three days up to a 
week to process the samples.  The time and expense required to obtain high quality DNA 
are the major drawbacks preventing gene synthesis technology from becoming more 
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mainstream.  Implementation of an enzymatic error correction step could greatly improve 
the quality of assemblies, which will reduce the number of clones that have to be 
sequence verified.  Integration of a digital microfluidics into DNA assembly coupled with 
error correction can potentially increase the throughput of gene synthesis.   
Digital microfluidic devices are applicable for gene assembly because DNA is 
typically handled in microliter amounts.  The microfluidic devices are capable of 
generating droplets in the microliter to picoliter range.  The microliter droplets act like 
reaction and transportation vessels.  The ability to program liquid handling operations 
such as split, merge, mix, and transport allows a researcher to simplify the gene assembly 
process.  Time-consuming steps like pipetting, transferring reagents, tube labeling, 
incubation at certain temperature, and thermocycling can be performed by programmable 
droplet generation and routing.  The sequential reactions can be carried on a single 
microfluidic cartridge without any human intervention.  Automation programs can be 
designed to conduct multiple experiments in parallel.  Since the devices are fully 
automated, the sources of human errors and labor costs can be greatly reduced.  In 
addition, DNA assembly protocols can be distributed between laboratories, so the 
scientists can use the equipment to generate novel ideas.   
Because DNA assembly and error correction reactions require the use of expensive 
enzymes, scaling down to smaller reaction volumes reduces reagent expenses.  Due to the 
large surface-to-volume ratio, microdroplet reactors have high heat and mass transfer 
rates.  This makes it possible to increase kinetics and speed up reactions.  Integration of 
effective error correction procedures has the potential to perform DNA assembly on a 
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single microfluidic cartridge without the need for expensive and lengthy sequence 
verification.   
The purpose of this research is to develop a DNA assembly protocol for a 
programmable digital microfluidic device.  The process consists of three major parts.  
First, oligos are assembled into a double-stranded DNA fragment.  The oligo assembly is 
then amplified by PCR.  The next step is to remove the errors, which came from the 
original oligonucleotides.  The repaired fragments are Sanger sequenced to verify the 
efficiency the error removal process.  The data is analyzed to determine the most efficient 
DNA assembly and error correction protocols.  The ultimate goal is to be able to design a 
reliable and cost- effective DNA assembly protocol that will be widely applicable in 
biological research. 
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CHAPTER TWO 
LITERATURE REVIEW 
In order to develop a rapid and cost-effective process, DNA assembly, amplification, 
and error correction procedures have to be adapted to the microfluidic platform.  This 
literature review will examine each step of the gene construction process and illustrate 
methods that have been successfully integrated with microfluidics.  Additionally, 
prevention of protein adsorption on microfluidic surfaces will be discussed.  
2.1 Gene Assembly Methods 
A number of DNA assembly protocols have been developed to date.  A summary of 
gene construction methods performed on microfluidic devices is shown in Table 1.  For 
the scope of this study, only assembly methods from oligonucleotides will be discussed.  
It can be observed that the most popular gene construction methods for microfluidic 
applications are polymerase-based and endonuclease-based assembly.  Both approaches 
utilize oligonucleotides as DNA building blocks.  Oligonucleotides are typically 10 to 
100 bases in length.  One of the requirements is that oligos need to have complementary 
sequences on both ends, so pieces could overlap to form a longer DNA strand [12].   
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Table 1.  Microfluidic assembly methods. 
Authors Type of 
microfluidics 
Assembly method Assembly 
size 
Error 
rates 
Kong et al. 
[13] 
Droplet Polymerase-based (PCA) 500 –1000 
bp 
1.78 
errors/kb 
Huang et al. 
[14] 
Microchannel Polymerase-based (PCA) 760 bp 4.1 
errors/kb 
Quan et al. 
[15] 
Microarray Polymerase-based 
(PCA) 
500 – 1000 
bp 
1.9 
errors/kb 
Tian et al. [16] Microarray Polymerase-based 
(PAM) 
14500 bp 2.2 
errors/kb 
Linshiz et al. 
[17] 
Chanel  Exonuclease-based 
(Gibson) and 
polymerase-based 
(IHDC) 
754 bp N/A 
Shih et al. [18] Combined 
digital and 
droplet 
microfluidics 
Exonuclease-based 
assembly of dsDNA 
(Gibson) 
2100 bp N/A 
Tangen et al. 
[19] 
Droplets Polymerase-based (PCA) 
and Exonuclease-based 
(Gibson) 
525 bp N/A 
Yehezkel et al. 
[20] 
Digital 
microfluidics 
Polymerase-based (POP) 800 bp 2.22 
errors/kb 
2.1.1 Polymerase-based DNA Assembly 
Polymerase cycling assembly (PCA) is one of the most popular polymerase-based 
DNA assembly techniques.  Polymerase cycling assembly procedures are similar to PCR. 
Instead of using forward and reverse primers, oligonucleotides overlap and serve as 
templates for a complimentary strand.  The oligos are designed to be either a part of the 
top or the bottom DNA strand.  As seen in Figure 6, in the first PCA cycle, oligos 
overlap, and the polymerase extends the complementary strand only in a 5’ to 3’ 
direction.  In the next cycle, the double-stranded DNA pieces are separated and 
overlapped with the oligonucleotides or other single-stranded fragments.  The process of 
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denaturation, annealing, and extension is repeated until the desired sequence has been 
built [21].  
 
Figure 6.  Polymerase cycling assembly (PCA) process flow [12] (reprinted with 
permission from Elsevier). 
Huang et al. used PCA to synthesize a 760 bp segment of GFPuv gene from a pool of 
oligonucleotides on a microfluidic device.  The group was able to join 39 chemically 
synthesized oligonucleotides, which were 20-40 bases-long, each overlapping another 
oligo by 20 bases.  The researchers demonstrated that a two-step assembly process based 
on PCA followed by PCR was more effective than a one-step assembly.  It has been 
shown that a two-step assembly produced a larger amount of the full-length product.  The 
yield of assembly on a microfluidic device was 50% lower than on a conventional 
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thermocycler.  The reaction yield was dependent on the dead-volume formed between the 
valves and a PCR chamber.  The oligos that were trapped in the dead volume were not 
assembled.  Sequencing results showed that the average error rate was 4.1 errors per 
thousand bases.  It has been determined that the majority of errors came from 
oligonucleotides [14].  
Quan and colleagues demonstrated that the oligonucleotide synthesis, amplification, 
and assembly could be achieved on a single microfluidic device.  Oligonucleotides were 
synthesized on a microarray surface using an inkjet DNA synthesizer.  Prior to assembly, 
the oligonucleotides were amplified and released from the microarray surface.  The 
oligos were assembled by the same PCA method described above into 0.5-1 kb      
double-stranded DNA fragments [15].  The error rate of assemblies has been found to be 
1.9 errors/kb, which is lower than the results obtained by Huang’s group [14, 15].   
Chip synthesized oligos were used by Tian and colleagues to assemble 21 protein 
coding genes of the E. coli 30s ribosomal subunit.  The group developed a hybridization 
method to remove oligos containing mutations.  Next, in a single step selected 
oligonucleotides were joined by a variation of the PCR-based assembly reaction, which 
they called a polymerase assembly multiplexing (PAM) reaction.  The intermediates were 
joined sequentially by PAM into protein coding genes with the approximate length of 
14.6 kb.  [16].  
Yehezkel at al. developed a polymerase-based assembly method called 
programmable order polymerization (POP).  The method was successfully automated on 
the Mondrian™ SP microfluidic device.  The assembly consisted of four phases.  In each 
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phase, one dsDNA piece was extended by two overlap extension oligos in 4 
denature/anneal cycles.  A dilution step was employed between each assembly step to 
remove primers from the previous step.  The group reported 1/450 bp (2.22 errors/kb) 
error rate for their assembly method.  The errors were identified as substitutions [20].  
Polymerase based methods are very robust and easy to perform, but have several 
disadvantages.  The assembly of long sequences will increase reaction time.  Since the 
quality of oligos decreases with the length, it is important to use shorter oligos for 
accurate gene assembly.  This means that for long sequences, the number of building 
blocks has to be higher, and the assembly reaction will require more denaturing, 
annealing, and extension cycles.  With each amplification cycle, errors, which came from 
oligos, will be amplified.  The use of an expensive high-fidelity polymerase is necessary 
to minimize amplification errors.  
2.1.2 Exonuclease-based Assembly Methods 
Among exonuclease mediated assembly methods, Gibson assembly is considered to 
be one of the most suitable for microfluidic applications.  It is a one-step isothermal 
assembly method developed at the J. Craig Venter Institute.  Double-stranded DNA 
pieces are joined into longer fragments by three enzymes, T5 exonuclease, DNA 
polymerase, and Taq DNA ligase.  The reagents are incubated at 50 ⁰C for an hour.  As 
shown in Figure 7, two oligonucleotides overlap at the 3’ end, and T5 exonuclease 
reveals these overlaps by digesting some DNA from each 5’ end.  Next, the 
complementary strands anneal and the gaps are filled in by the action of Phusion 
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polymerase.  Taq ligase creates covalent bonds between annealed complementary strands 
by removing sequence discontinuities [22].   
 
Figure 7.  Gibson assembly.  (Reprinted by permission from Macmillan Publishers Ltd.: 
[Nature Methods] ([22]), copyright (2009). 
Gibson Assembly can be utilized to build short DNA fragments or full functional 
genomes.  The mouse mitochondrial genome (16.5 kb) was synthesized by assembling 
600 oligos in four stages.  After each stage, PCR amplification was used to increase the 
concentration of assembly intermediates.  In order to obtain an error-free genome, 
intermediate sequences were cloned and sequenced.  It has been shown that assemblies 
had one error per every 325 bp, which resulted in only one of four error-free clones.  
Only error-free clones were used for the next assembly stage [6].  
Akama-Garren et al. developed modular gene assembly platform (GMAP) based on 
the Gibson method.  Five oligonucleotides were designed to code for 30 common 
promoters and 140 genes with 30 bp overlaps.  The researchers were able to reduce the 
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assembly time to 20 min instead of the original one hour proposed by Gibson et al. [22].  
The assemblies were successfully inserted into viral backbones.  This method allows a 
researcher to assemble oligos into complex functional genes in less than one day [23]. 
It has been shown that Gibson assembly can be successfully integrated into a 
microfluidic gene synthesis process.  Shih et al. designed a microfluidics device that 
combined droplet-based and microchannel microfluidics.  The microfluidic chip had 
three compartments designed for the assembly of plasmids from dsDNA fragments, 
electroporation, and incubation.  The configuration of the microchip enabled 16 
simultaneous assembly reactions [18].   
Linshiz et al. developed an automated microfluidic platform that combined 
polymerase-based and Gibson gene construction methods.  As shown in Figure 8, eight 
oligos were combined by an isothermal hierarchical DNA construction method (IHDC) 
into one 754 bp fragment.  This method annealed overlapping single-stranded DNA 
pieces and elongated them using a polymerase.  Next, Gibson Assembly was used to 
clone the insert into pETBlue-1 plasmid.  Gibson assembly combined with IHTC took 
two hours.  Similarly to Shih’s group, transformation of E. coli with the pETBlue-1 
plasmid was performed on the microfluidic device [17].   
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Figure 8.  Isothermal hierarchical DNA construction coupled with Gibson assembly 
(reprinted with permission from BioMed Central Ltd.) [17]. 
Gibson assembly has several advantages over PCR-based assembly methods.  It has 
been shown that Gibson reaction time could take from 20 min to one hour [22, 23].  On 
the other hand, an average 30 cycle PCR takes at least 45 min.  Gibson assembly is 
carried out isothermally, whereas PCR requires thermocycling between two or three 
temperatures.  Microchips have to be designed for continuous thermocycling.  Thus, 
polymerase-based assembly methods are more challenging for integration on microfluidic 
devices.  The isothermal process eliminates cross-contamination between samples since 
the reagents are not moved around on a microfluidic surface.  Additionally, Gibson 
assembly does not increase sequence errors because each oligo serves as a template for a 
complimentary strand only once.  In polymerase assembly, the growing DNA sequence 
serves as a template multiple times until the fragment is built.   
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2.2 Microfluidic PCR 
Gene assembly products are typically produced in low concentrations.  The next step 
in gene synthesis is amplification of DNA, so it can be used in subsequent biological 
manipulations.  Polymerase chain reaction is often utilized for DNA amplification.  
Several studies have been done for PCR optimization on microfluidic devices.  Wang et 
al. performed PCR utilizing a droplet microfluidic device with automated heating and 
temperature control.  The researchers investigated the influence of polymerase and 
magnesium concentration on the reaction yield.  It has been found that microfluidic PCR 
requires a 7-fold increase of polymerase in order to achieve sufficient amplification yield.  
On the other hand, the optimum magnesium ion concentration of 3.5 mM was the same 
for both reaction settings, but the chip-based reaction was more sensitive to magnesium 
fluctuations.  It has been suggested that polymerase and magnesium were precipitating 
out of droplets, so they had to be used in excess [24, 25].  
Microfluidic PCR is more time efficient than conventional bench-top PCR.  
Microfluidic PCR achieved a threshold value of 10 cycles earlier than the same reaction 
performed using bench-top conditions [25].  Huang et al. demonstrated that reaction time 
on a flow through microfluidic platform was reduced by 64% relative to benchtop [26].  
Microfluidic surfaces are prone to biofouling.  Cartridges or microfluidic channels are 
usually coated with either Teflon or Poly(dymethylsiloxane).  Both coatings are 
hydrophobic and susceptible to adsorption of biomolecules.  Yoon and Garrell 
demonstrated that adsorption was caused by a combination of hydrophobic and 
electrostatic interactions arising from an applied electrical field [27].  The enzymes 
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trapped on the surface have reduced activities and have to be used in excessive amounts 
in order to achieve the desired reaction yield.  In addition, biofouling can lead to 
malfunction of a cartridge if it interferes with droplet movement.  If the surface has a 
buildup of contaminants, it would affect electrowetting.  The droplets will not be able to 
move through this area, which leads to experimental failures.  In order to obtain robust 
microfluidic PCR, the adsorption must be minimized.  
Adsorption of DNA polymerase on microfluidic surfaces has been found to be one of 
the main factors reducing PCR yield.  Prakash et al. studied adsorption of Taq 
polymerase on Teflon coated surfaces [28]  It has been shown that adsorption of 
polymerase reduced contact angle of a micro droplet.  The reduced contact angle was 
stable and did not change overtime.  The same trend was shown while measuring the 
concentration of polymerase.  The concentration of polymerase reduced from 0.29 to 0.22 
mg/mL as soon as the droplet contacted the Teflon surface and did not change in 300 s.  
It has been determined that the saturation concentration of polymerase on the Teflon 
coated surface was 0.07 mg/mL [28].  
Several ways to minimize fouling were investigated.  Erill and colleagues studied the 
adsorption of Taq enzyme on silicon chips [29].  Surface effects were reduced by the 
addition of bovine albumin serum (BSA) as well as by increasing the Taq polymerase 
concentration.  Figure 9 shows that the addition of 0.05 µg/µL of BSA greatly increased 
PCR yield.  It has been suggested that polymerase and BSA compete for adsorption sites, 
but BSA has a higher affinity.  The addition of BSA up to 2.5 µg/µL eliminated 
polymerase adsorption [29].  
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Figure 9.  Polymerase adsorption experiments (reprinted with permission from Elsevier) 
[29]. 
Xia and colleagues studied prevention of protein adsorption by comparing dynamic 
and static passivation with polyethylene glycol (PEG) and poly(vinylpyrrolidone) (PVP) 
on PDMS-glass PCR chips [30].  The solutions containing 10% of polymer were used to 
pre-coat the surface prior to PCR reaction.  In addition, the polymer solutions 0.4% w/v 
were added into PCR mixes.  Figure 10 demonstrates that passivation with 10% PVP 
10,000 and PVP 55,000 increased relative PCR efficiency.  It has been suggested that 
polymers with higher molecular weight were trapped in the PDMS matrix.  Polymerase 
could not adsorb on the surface that led to the reduction of surface effects and an increase 
in PCR efficiency [30].   
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Figure 10.  Relative PCR efficiency on PDM-glass chip coated with 10% polymer 
solutions and polymer solutions added into reaction Mix 0.4% w/v (reprinted with 
permission from John Wiley and Sons) [30]. 
One of the possible solutions to biofouling on Teflon-AF surfaces could be the use of 
Pluronic molecules, which are triblock polymers formed from poly(ethylene oxide) 
(PEO) and poly(propylene oxide) (PPO) chains.  Luk et al. demonstrated that the addition 
of Pluronic F127 (0.08% w/v) into a protein solution significantly reduced adsorption.  
Figure 11 shows the results of confocal microscopy of FITC-BSA, FITC-Casein, and 
Alexa Fluor-488Fb with and without a F127 adjuvant (0.08% w/v).  Also, it has been 
determined that the addition of Pluronic F127 showed 1000-fold increase of maximum 
concentration of a protein permitting droplet to move on the surface without sticky 
effects [31].  Prevention of protein adsorption on the DMF surfaces is possible due the 
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formation of ordered Pluronic layers on the oil/water interface.  A stabilized interface can 
eliminate the hydrophobic interactions between proteins and the surface.  
     
Figure 11.  Results of confocal microscopy of Pluronic additive on protein adsorption.  
(Reprinted with permission from [31].  Copyright (2008) American Chemical Society. 
Au et al. examined the effects of eight different Pluronic polymers on DMF 
longevity.  The droplets containing 10% fetal bovine serum and 0.02% w/v of Pluronic 
were moved on the surface until movement failure.  Figure 12 shows that Pluronics with 
PPO chains greater than 30 molecular units (F64, F68, L92, and P105) facilitated droplet 
movement and prolonged actuation time [32]. 
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Figure 12.  Results of Pluronic type effects on maximum actuation time (Reprinted with 
permission from ([32]).  Copyright (2011) American Chemical Society. 
A reduction of actuation voltage on EWOD cartridges prevents nonspecific 
adsorption of proteins on microfluidic surfaces.  At high voltage when the droplets are 
transported from one energized electrode to another, the oil film between the microfluidic 
surface and the aqueous droplet breaks down [33].  Under these circumstances, the 
exposed Teflon surface could easily be contaminated by hydrophobic proteins such as 
DNA polymerase.  Another factor is that the amount of surfactant has to be adjusted for 
reactions that are carried out at elevated temperatures.  The critical micellar concentration 
of nonionic surfactants such as Tween 20 decreases with temperature [34].  Thus, less 
surfactant is needed for reduction of a surface tension at high temperatures.  According to 
Yehezkel et al., the amount of Tween 20 for the Mondrian™ SP microfluidic cartridge 
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should be 0.01-0.05%, and the operation voltage during thermocycling should be 90 V 
[20].  
2.3 Reduction of Errors in Synthetic Genes 
Genes that are assembled from oligonucleotides typically contain errors that can 
significantly alter the quality or expression of target proteins.  It has been reported in the 
literature that the majority of the errors in genes originated from the oligonucleotide 
synthesis.  Some errors are introduced during PCR, but the rate is sufficiently low [14, 
16].  During DNA assembly, oligonucleotides are used as templates for complementary 
strand synthesis.  If the oligos contained errors, the complementary strand will have them 
as well.  Furthermore, the assembly is usually followed by an amplification step, in which 
the errors will be propagated with each cycle.  As the result, genes synthesized from 
oligonucleotides will almost always have errors.  Screening for mutations and sequencing 
are necessary steps for obtaining high quality error-free genes, but these steps are 
expensive and time-consuming.  There are error correction methods that can improve the 
quality of synthetic genes.  If assemblies have less mistakes, the number of screened 
colonies will be lower, with a consequent reduction in time and cost.  Current error 
correction methods are based on DNA mismatch removal by mismatch cleaving 
enzymes.  Several researchers investigated enzymatic error correction of synthetic genes.  
Fuhrman and colleagues tested the effectiveness of three enzymes: T7 endonuclease I, 
T4 endonuclease VII, and E.coli endonuclease V on removing mutations from synthetic 
genes [35].  It has been shown that T4 endonuclease VII and E.coli endonuclease V were 
effective in reduction of insertions and deletions, but T4 endonuclease required 24 hours 
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to achieve the same level of correctness as E.coli endonuclease V produced in 4 hours 
[35]. 
Kosuri and colleagues used a commercially available enzyme mix, ErrASE.  The mix 
contains resolvases that target and cleave mismatches as well as additional enzymes that 
remove cleaved fragments from the sequence.  Six different enzyme concentrations were 
tested.  All experiments resulted in successful error removal, but the highest 
concentration was chosen.  After error correction, the assemblies were cloned and 
screened for errors.  The group found that the error rate after the treatment with ErrAse 
was 1/7,170 bp (0.13 errors/kb).  By comparison, the average error rate was 1/250 bp (4 
errors/kb) before the ErrASE treatment [36].  
Quan et al. used a commercial Surveyor nuclease enzyme to correct errors.  The 
Surveyor nuclease is a mismatch-cleaving enzyme that is specifically used for a gene 
mutation identification.  The group performed denaturation and renaturation of 
assemblies followed by an enzymatic treatment.  Furthermore, DNA was amplified by 
PCR.  The researchers observed a 10-fold error reduction in samples that were treated by 
the nuclease [15]. 
Surveyor nuclease was used by Saaem et al. to repair chip synthesized genes.  As 
shown in Figure 13, DNA fragments were denatured and allowed to reanneal to form 
heteroduplexes.  Mismatches in heteroduplexes were cleaved during incubation with 
Surveyor exonuclease.  During PCR, single-stranded overhangs were chewed back by the 
proofreading activity of Phusion polymerase, and corrected sequences were amplified 
[37].  The researchers tested 20 min and 60 min incubation times as well as two rounds of 
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error correction against one round.  Figure 14 demonstrates that the strategy of 
implementing multiple iterations of error correction was more effective than increasing 
the incubation time.  The sequencing results showed that two rounds of error correction 
with 60 min incubation time reduced errors from 0.26 to 0.11 errors/kb, which was 58% 
error reduction compared to a single round of error correction [37].  
 
Figure 13.  Schematic of error correction procedure (reprinted with permission from 
Oxford University Press) [37]. 
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Figure 14.  Effect of incubation times and iterations on error correction results (reprinted 
with permission from Oxford University Press) [37]. 
According to the Gibson group, error reduction in synthetic genes was even more 
efficient when Surveyor nuclease treatment was followed by Exonuclease III treatment 
(Dan Gibson, personal communication).  The error frequency was reduced from 0.6 
errors/kb to 0.16 errors/kb.  The method of error reduction by simultaneous action of 
Surveyor and Exonuclease III was disclosed [38].  
Sequeira et al. demonstrated an effective error reduction in synthetic genes based on 
T7 endonuclease I.  It was determined that the enzyme improved fidelity of genes by 8-
fold with an error frequency reduction from 3.45 errors/kb to 0.43 errors/kb.  
Endonuclease was effective at reduction of deletions and insertions, but it increased the 
rate of substitutions.  In contrast, the error frequency of the samples treated with 
CorrectASE™ enzyme was 1.22 errors/kb.  The CorrectASE™ reduced deletions, but 
increased substitutions and insertions [39].  
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2.4 Literature Review Summary 
Different methods for obtaining error-free synthetic genes were discussed in the 
literature.  It has been shown that various assembly methods can be used for microfluidic 
gene assembly.  Gibson assembly has the potential for miniaturization since it is an 
isothermal process.  Additionally, one pot reactions are the most suitable for microfluidic 
applications because they save time and prevent cross-contamination and reagent losses.  
Polymerase chain reaction is extensively used in DNA synthesis.  However, 
microfluidic PCR is not as effective as conventional PCR due to surface effects.  Erill et 
al. determined that the adsorption of polymerase on microfluidic surfaces reduces 
reaction efficiency [29].  Numerous methods have been developed in order to overcome 
polymerase adsorption.  Among those methods is increase of polymerase concentration, 
addition of BSA and Pluronics, reduction of actuation voltage as well as pre-passivation 
with PEG.   
Error correction of synthetic DNA utilizing mismatch-cleaving enzymes has been 
used for the reduction of errors.  Saaem et al. demonstrated that two rounds of error 
correction with Surveyor endonuclease reduced error rates by 58% over a single round of 
error correction, with a final error rate of 0.1errors/kb [37].  Gibson et al. demonstrated a 
two-step error reduction method with Surveyor nuclease and Exonuclease III [38].  
Improvement of sequence fidelity was also achieved with T7 endonuclease [39].  
Enzymatic error correction has never been reported on microfluidic devices. Thus, more 
research is needed in order to develop an effective error-free gene assembly protocol. 
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CHAPTER THREE 
RESEARCH OJECTIVES 
3.1 Research objectives 
The purpose of this research is to develop a robust and accurate DNA assembly 
protocol that utilizes the Mondrian™ SP digital microfluidic device manufactured by 
Illumina, Inc.  The research consists of three objectives.  The first objective is to program 
a protocol using automated microdroplet generation and routing.  The second objective is 
to determine suitable operation conditions for three reactions: Gibson assembly, 
polymerase chain reaction, and enzymatic error correction.  Finally, these reactions are 
combined in a single protocol that is utilized for the assembly of 12 oligos with two 
CorrectASE™ treatments on the microfluidic device.  The third objective is to verify the 
effectiveness of DNA assembly and enzymatic error correction methods by Sanger 
sequencing. 
3.2 Justification 
Rapid and cost-effective synthesis of error-free genes remains one of the main 
challenges in synthetic biology.  Digital microfluidic devices offer an opportunity to 
automate and simplify complicated procedures.  Electrowetting-on-dielectric systems 
allow precise generation of microdroplets in the nanoliter to microliter range.  The same 
volumes cannot be accurately measured by a conventional micropipette.  An increase in 
the throughput of gene assembly is achieved by parallelization of reactions and the 
reduction of reaction volume.  Integration of effective DNA assembly and error 
correction protocols on the DMF device reduces the time and cost of DNA assembly. 
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CHAPTER FOUR 
MATERIALS AND METHODS 
The main goal of this study was to develop a robust and reliable DNA assembly and 
error correction protocol for the Mondrian™ SP DMF device provided by Illumina, Inc. 
A partial sequence (339 bp) originated from the human influenza virus hemagglutinin 
(HA) gene was assembled from 12 oligonucleotides and error corrected twice.  The 
whole protocol involved six consecutive enzymatic reactions.  Prior to incorporating the 
six enzymatic steps of the gene synthesis in a complete protocol, each enzymatic step was 
performed separately to find the most favorable reaction conditions.  The details on how 
suitable operation procedures were established are described in subsequent sections.  The 
experiments were carried out on Mondrian™ SP DMF cartridges.  All liquid handling 
operations were programmed using the Application Development Environment software 
(Illumina, Inc.).   
4.1 Equipment 
4.1.1 Mondrian™ SP Microfluidic Device 
The experiments were performed on the Mondrian™ SP microfluidic system.  As 
shown in Figure 15, the system included a device that was connected to a computer and 
digital microfluidic cartridges that were inserted into the device.  To observe the behavior 
of the microscopic droplets, the device was connected to a digital camera that produced a 
magnified image of the DMF cartridge onto a screen.  Figure 16 shows a microfluidic 
Mondrian™ SP cartridge that was used in the experiments.  The cartridge consisted of 
two plates, a glass top and a printed circuit board (PCB) substrate.  The area between the 
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plates was filled with a 2 cSt silicone oil.  The configuration of the DMF cartridge 
allowed eight processes to be performed in parallel.  The reagents were loaded through 
ports on the cartridge, and the samples were withdrawn through other ports.  The 
microfluidic cartridge had three heater bars that contacted the back of the PCB, which 
was used to set temperatures for the enzymatic reactions.  Additionally, the cartridge 
could be cooled down with Peltier device.  The device was operated by the Application 
Development Environment software.  Prior to each experiment, a program was designed 
to direct droplets’ liquid handling operations.  The device was operated at a voltage of 90 
V or 300 V and a frequency of 30 Hz.   
 
Figure 15.  An image of the Mondrian™ SP device used in this study. 
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Figure 16.  An image of Mondrian™ SP microfluidic cartridge. 
The liquid volumes of 0.3, 0.6, and 1.2 µL, referred to as 1X, 2X, and 4X droplets, 
respectively, were generated and manipulated on the microfluidic cartridge.  As seen in 
Figure 17, to dispense a 1X droplet, three electrodes adjacent to the reagent input port 
were activated, which caused the liquid to spread over three electrodes.  Then, the 
electrode #2 was switched off.  The double 2X droplet was dispensed by turning off the 
electrode #3.  To create a 4X droplet, the electrode between two 2X droplets was turned 
on.  
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Figure 17.  Generation of 1X, 2X, and 4X droplets on the DMF. 
4.1.2 Bacterial Electroporation Transformation Equipment 
A Bio-Rad Gene Pulser II Porator electroporation system, shown in Figure 18, was 
used to transform E. coli cells with recombinant DNA.  The system consisted of 
electroporator, pulse chamber, cuvette cell holder, and 0.1 cm cuvettes.  It was operated 
at 25 µF and 1.8 kV.  The electroporation cuvette with E. coli cells and synthetic DNA 
was put in a cuvette holder that was inserted into the pulse chamber.  The cells were 
subjected to a voltage that created pores in cell membranes allowing synthetic DNA to 
pass to the inside of the cells.  
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Figure 18.  Bio-Rad Gene Pulser II Porator electroporation system. 
4.1.3 DNA Analysis Equipment 
The presence and size of nucleic acids were analyzed by DNA gel electrophoresis.  
The samples were loaded on a 2% agarose gel that was inserted in an electrophoresis 
chamber.  The chamber was filled with 1X TAE electrophoresis buffer (Thermo Fisher 
Scientific) and connected to the power source.  When the gel was subjected to an electric 
current, DNA molecules migrated from a negative electrode to a positive electrode.  
The concentration of DNA samples was measured using a NanoDrop ND-1000 
spectrophotometer, shown in Figure 19.  The NanoDrop instrument is designed to 
measure DNA absorbance at 230 or 260 nm.  To measure concentration, a 1 µL sample 
was pipetted on a lower sample pedestal.  Then, the sample was locked between the 
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lower pedestal and a sample arm, and the absorbance was measured.  The concentration 
of nucleic acids in ng/µL was calculated and displayed by the system software installed 
on a computer connected to the instrument.  
 
Figure 19.  An image of the NanoDrop ND-1000 instrument. 
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4.2 Experimental Procedures for Microfluidic Polymerase Chain Reaction 
Amplification of assembled DNA by polymerase chain reaction is the second step of 
gene assembly.  In order to develop a successful DNA assembly protocol, PCR 
performed on the DMF cartridge must be robust and reliable.  Microfluidic PCR is 
challenging for the reasons discussed in Chapter 2.  The first challenge for the process 
used in this study was to demonstrate that PCR could be performed on the microfluidic 
device.  The second challenge was to prevent biofouling of the DMF cartridge.  The 
subsequent subsections detail the experiments and logic designed to achieve the 
following objectives.  
 Determine PCR reagents that lead to successful and consistent DNA 
amplification on the microfluidic device.  
 
 Improve the on-cartridge droplet transfer process during PCR – reduce 
biofouling.  
 
 Automate droplet generation and routing for PCR. 
The materials used in the following subsections are shown in Appendix A.  
4.2.1 Optimization of PCR Reagents  
In this section the experiments were performed to determine reagent compositions for 
successful microfluidic PCR.  It was established in preliminary benchtop experiments 
that 30 cycles of PCR amplification were sufficient to obtain a band that was visualized 
by DNA electrophoresis.  According to Erril et. al, microfluidic amplification of DNA 
was improved by increasing the concentration of polymerase [29].  Thus, the amount of 
Phusion polymerase was increased by 5-fold in a basic microfluidic protocol.  Table 2 
shows the DMF protocol that was used as a baseline for microfluidic PCR experiments.  
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Table 2.  Basic microfluidic PCR protocol. 
Reagent Concentration 
Phusion detergent-free buffer (Thermo Fisher 
Scientific) 
1X 
Forward and reverse PCR primers (IDT DNA) 0.8 µM 
HA-049 DNA template 
(Prepared by the J. Craig Venter Institute) 
1.75 ng/µL 
Tween 20 (Sigma Aldrich) 0.0025% 
Phusion polymerase 
(Thermo Fisher Scientific) 
0.1 U/µL 
DNAse, RNAse-free UltraPure™ DI water  
(Invitrogen) 
Up to a final volume 
Many experiments were conducted utilizing the basic microfluidic PCR protocol.  
None of these attempts were successful because no amplification was achieved.  By trial 
and error, it was determined that PCR worked using templates that had previously been 
assembled using Gibson assembly.  It was hypothesized that Gibson isothermal (iso) 
buffer or additional Phusion was responsible for the improvement of PCR performance.  
The experimental plan to determine appropriate PCR reagents for this study is shown in 
Table 3.  
Run 1 was performed to mimic reagents of the PCR reaction that was done after 
Gibson assembly.  Since the Gibson reaction contains Gibson iso buffer and Phusion 
polymerase, the addition of extra Phusion or the iso buffer or a combination of both was 
tested.  For these experiments, the baseline microfluidic protocol was modified.  The 
difference between the reactions was that one contained additional 1X Gibson iso buffer 
and 0.025 U/µL of Phusion polymerase.  The second master mix had only additional 
0.025 U/µL of Phusion while the third mix contained only additional 1X Gibson iso 
buffer.  The last sample was a negative control, so there were no additional reagents.  The 
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experiments conducted in Run 1 demonstrated that the iso buffer remaining from the 
Gibson assembly reaction improved amplification yield.   
Table 3.  Experimental design to determine microfluidic PCR conditions.   
Run No. Treatment type Variables (final concentrations in 
reaction) 
1 
Mimic the same conditions as 
PCR after assembly reaction 
0.125 U/µL Phusion  
0.125 U/µL Phusion + 1X Gibson iso 
buffer 
1X Gibson iso buffer 
Control – 0.1 U/µL Phusion 
2 
PCR with PEG against the iso 
buffer 
1 mM MgCl2 
1.25 mM PEG 8000 
0.2 mM NAD 
2 mM DTT 
3 
PCR with combination of PEG 
and the other components of 
Gibson iso buffer 
1X Gibson iso buffer 
1.25 mM PEG + 1 mM MgCl2 
1.25 mM PEG + 0.2 mM DTT 
1.25 mM PEG + 2 mM NAD 
In Run 2, four individual components of Gibson iso buffer were tested to see which 
component was responsible for the PCR improvement.  To prepare reagents for Run 2, 
four different solutions were mixed.  The amount of polymerase, polymerase buffer, 
dNTPs, Tween 20, and PCR primers was kept the same as in Table 2.  The only 
difference was that each master mix contained either additional 1 mM MgCl2, 1.25 mM 
PEG 8000, 0.2 mM NAD or 2 mM DTT.  The results of Run 2 demonstrated that addition 
of PEG 8000 slightly improved the amplification yield, but it was not as effective as with 
the iso buffer additive.  
Run 3 was conducted to see if the combination of PEG 8000 and one of other three 
components of the iso buffer were responsible for successful amplification on the DMF 
cartridge.  To prepare reactions for Run 3, a combination of 1.25 mM of PEG 8000 with 
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either 1 mM MgCl2, 0.2 mM NAD or 2 mM DTT were tested against the 1X iso buffer.  
The rest of the reagents were prepared according to Table 2.  The results of Run 3 
demonstrated good amplification of DNA when the reaction was supplemented with extra 
MgCl2, Phusion, and PEG 8000.   
4.2.2. Reduction of Phusion Polymerase Adsorption During Microfluidic PCR 
Microfluidic PCR was very challenging due to surface contamination with Phusion 
polymerase.  The experiments showed that during microfluidic PCR, droplets in the      
98 ⁰C zone were not wetting activated electrodes.  At these conditions, the oil/water 
interface became unstable, and the polymerase was adsorbed on the microfluidic surface.  
When the polymerase stuck to the surface, it reduced the amount of enzyme available for 
the reaction.  Another issue encountered was that the droplets were releasing gas bubbles.  
The resulting air bubbles were blocking pathways, pushing droplets off the electrodes and 
out to the gas vents.  This made it difficult to transport the droplets in a reproducible 
manner and to retrieve samples from the cartridge.   
Multiple methods discussed in Chapter 2 were used to strengthen the oil/water 
interface of a liquid droplet.  The experimental plan shown in Table 4 was designed with 
the aim to reduce polymerase adsorption on the microfluidic surface, to improve the 
droplet fluidics in the hot zone of the cartridge, and to achieve the same level of 
amplification as on the benchtop. 
It has been shown by Erril et al., that the addition of bovine serum albumin (BSA), 
which formed stronger hydrophobic interactions with the microfluidic surface, prevented 
adsorption of polymerase on the microfluidic surface and reduced the amount of enzyme 
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to achieve good amplification [29].  Run 1 was performed to see if the addition of 0.1 
µg/µL of BSA would prevent Phusion polymerase adsorption on the microfluidic surface, 
increase PCR yield, and reduce the amount of enzyme needed for successful 
amplification.  For Run 1, four reactions were performed.  The amount of Phusion was 
varied to observe the effect of BSA on adsorption.  In each reaction, the concentration of 
Phusion was either 0.02, 0.08, 0.14, or 0.2 U/µL, which was 1X, 4X, 7X, and 10X 
amount of enzyme relative to a standard benchtop PCR.  If PCR worked at 1X Phusion 
concentration, it would suggest that the adsorption was eliminated.  Alternatively, 
amplification of DNA with 4X and 7X Phusion indicated some reduction of adsorption.  
Amplification with 10X Phusion would demonstrate no reduction of adsorption.  The 
Final concentration of reagents in PCR mixes were 1X HF detergent-free buffer, 0.25 
mM of each dNTP, 0.8 µM of forward and reverse primers, 0.14 ng/µL DNA template, 
0.0025% of Tween 20, 1.25 mM PEG 8000, 1 mM MgCl2, and DI water up to a volume 
of 50 µL. 
Since Au et al. demonstrated that Pluronic substances improved droplet transfer of 
concentrated protein solutions and reduced protein adsorption, Pluronic F68 was added to 
PCR reactions [32].  Runs 2 and 3 were performed to see if Pluronic F68 could 
strengthen the oil/water interface of a droplet and prevent polymerase adsorption.  In Run 
2, the concentration of Pluronic F68 was kept constant while the concentration of 
polymerase varied.  The reaction mixes were prepared the same way as in Run 1, but 
instead of BSA, Pluronic F68 was added in a final concentration of 0.02% w/v.  To 
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optimize the amount of Pluronic F68, in Run 3, the concentration varied from 0.04% to 
0.1%.   
Table 4.  Experimental design for polymerase adsorption.  
Run 
No. 
Treatment type 
Final concentration of 
Phusion polymerase 
in PCR 
Variables (final 
concentrations) 
1 Addition of BSA 
0.02 U/µL of Phusion 
0.1 µg/µL of BSA 
0.08 U/µL of Phusion 
0.14 U/µL of Phusion 
0.2 U/µL of Phusion 
2 
Addition of 
Pluronic F68 
0.02 U/µL of Phusion 
0.02% w/v of Pluronic F68 
0.08 U/µL of Phusion 
0.14 U/µL of Phusion 
0.2 U/µL of Phusion 
3 
Addition of 
Pluronic F68 at 
different 
concentrations 
0.02 U/µL of Phusion 
0.04% w/v of Pluronic F68 
0.06% w/v of Pluronic F68 
0.08% w/v of Pluronic F68 
0.1% w/v of Pluronic F68 
4 
Pre-coat lanes with 
different types of 
PEG 
0.02 U/µL of Phusion 
10% w/v PEG 8000 
10% w/v PEG 6000 
10% w/v PEG 4000 
10% w/v PEG 3350 
5 
Pre-coat lanes with 
PEG 8000 
0.02 U/µL of Phusion 
10% w/v PEG 8000 
0.08 U/µL of Phusion 
0.14 U/µL of Phusion 
0.2 U/µL of Phusion 
6 
Reduction of 
actuation voltage 
0.02 U/µL of Phusion 90 V 
Xia et al. demonstrated that biofouling could be greatly reduced if the microfluidic 
surface was pre-coated with different molecular weight PEG solutions [30].  In Runs 4 
and 5, different types of PEG were tested to see if this approach worked for the 
microfluidic device used in this study.  In Run 4, the experimental lanes were coated with 
10% w/v solutions of PEG 8000, PEG 6000, PEG 4000, and PEG 3350.  The 
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amplification was carried with the same amount of Phusion polymerase as on benchtop to 
see if the adsorption of the enzyme was eliminated.  In Run 5, the experimental lanes 
were coated with 10% PEG 8000, and the concentration of Phusion varied.   
Yehezkel et al., carried out PCR on the Mondrian™ SP cartridge at a reduced voltage 
of 90 V [20].  Thus, Run 6 was performed to see if lower actuation voltage improved 
droplet movement between the denaturation and annealing zones.  The reaction mix was 
prepared with the same final concentration of HF detergent-free buffer, dNTPs, DNA 
template, PCR primers, Tween 20, MgCl2, and PEG 8000 as in Run 1.  The concentration 
of Phusion was 0.02 U/µL, which is a standard amount of enzyme used in a benchtop 
PCR.  
Pluronic solutions of 0.02%, 0.04%, 0.08%, and 0.1% were prepared from a 10% 
stocks of Pluronic F68 by mixing it with DI water.  To prepare 10% w/v PEG 8000, PEG 
6000, PEG 4000, and PEG 3350, 1 g of solute was dissolved in 10 mL of DI water.  The 
solutions were mixed in a shaker until the solute was completely dissolved.  
Forward and reverse primers were prepared from 100 µM stock solutions by diluting 10 
µL of each in 80 µL of DI water.  A blend of 25 mM dNTPs was prepared from 100 mM 
deoxynucleotide kit by mixing equal amounts of dATP, dGTP, dCTP, and dTTP.  Diluted 
deoxynucleotides and primers were stored at –20 ⁰C in the freezer.  
4.2.3 Automation Program for Microfluidic PCR 
To perform microfluidic amplification experiments shown in Tables 2 and 3, an 
automation program for the DMF was developed.  The reactions were carried out in 1.2 
µL droplets, which are described in this manuscript as 4X.  The droplets were brought to 
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the PCR area, which consisted of two temperature zones.  The denaturation zone was set 
to 98 ⁰C, and the annealing/extension zone was set to 72 ⁰C.   
The thermocycling procedure for experiments in Table 3 and Runs 1-5 in Table 4 is 
described below.  During thermocycling, the droplets were moved at a speed of 3 
s/electrode.  There was no need to hold the droplets in the denaturation area because the 
slow transport took about 5-10 s, which was a sufficient time at 98 ⁰C for denaturation.  
In the 72 ⁰C area, the droplets were oscillated for 10 s to allow enough time for primer 
annealing and polymerase extension.  Oscillation of the droplets in the 72 ⁰C area was 
achieved by activation and deactivation of the electrodes every 500 ms.  When 
thermocycling was finished, the heater responsible for denaturation zone was shut down, 
and the droplets were held at 72 ⁰C for 5-10 min to allow final extension.  After the final 
extension, the reaction products were brought to the collection reservoirs and recovered 
manually.  
The thermocycling procedure was modified for Run 6 in Table 3.  The droplets were 
transported to the area where the voltage was reduced to 90 V.  Then, the droplets were 
moved to the 98 ⁰C zone where they were held for 30 s to perform initial denaturation.  
After, 30 cycles of PCR were performed.  During thermocycling, the droplets were 
transported from 98 ⁰C to 72 ⁰C at 1.5 s/electrode, and from 72 ⁰C to 98 ⁰C at                  
1 s/electrode.  Annealing/extension was done by oscillation of the droplets at 72 ⁰C for  
20 s, and denaturation was performed by holding the droplets at 98 ⁰C for 10 s.  After    
30 cycles of PCR, DNA was held for 10 min at 72 ⁰C to allow final extension.  Then, the 
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voltage was switched back to 300 V, so the samples could be transported to the collection 
reservoirs.  
4.3 Experimental Procedures for Microfluidic Gibson Assembly 
The experiments described in subsequent subsections were performed to achieve 
following objectives.  
 Optimize microfluidic Gibson assembly of 12 oligos. 
 
 Optimize dilution of assembly product prior to PCR.  
 Determine PCR conditions that lead to a consistent amplification of assembly 
products. 
 
 Develop an automation program for Gibson assembly followed by PCR. 
A comprehensive list of reagents used in Gibson assembly is shown in Appendix A.  
4.3.1 Optimization of Gibson Assembly Reaction Time and Determination of Suitable 
Reagent Concentrations 
The experiments described in this subsection were performed to determine suitable 
operation conditions for Gibson assembly on the DMF.  The reaction time was 
investigated.  Additionally, the assembly process was performed with and without T5 
exonuclease.  The experiments were conducted according to Table 5.   
It has been shown in the literature that typical assembly time is 15-60 minutes [22].  
Run 1 tested the reaction time on the microfluidic cartridge.  The reaction was performed 
in the presence of T5 exonuclease.  The final concentration of oligos in the reaction was 
250 nM.   
The main function of T5 exonuclease is to chew back DNA in a 5’ to 3’ direction and 
expose overhangs for annealing of two dsDNA strands.  However, when oligos are 
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assembled, exonuclease can degrade them.  In Run 2, the experiments were set up to see 
the influence of T5 exonuclease on the assembly of 250 nM oligos.  The reactions were 
performed in different droplets to investigate reproducibility.  
Table 5.  Microfluidic DNA assembly experiments. 
Run No. 
Oligonucleotide concentration in 
assembly reaction (mole) 
Assembly 
time (min) 
Presence of T5 
exonuclease in 
assembly 
master mix 
1 250 nM 
15 min 
Present 
30 min 
45 min 
60 min 
2 250 nM 60 min 
Not present 
Present 
 
In each experiment, 50 µL master mixes were made from fresh reagents.  Assembly, 
oligo, and PCR master mixes were prepared with the double amounts of reagents.  Equal 
size droplets were merged on the cartridge, to obtain a 1X final concentration.  The oligo 
master mix was prepared by the dilution of a 1 µM stock solution in DI water.  The oligo 
mix also contained 0.01% of Tween 20.  The surfactant was a necessary component to 
reduce a surface tension, which facilitated droplet dispensing and movement.  The 
amount of surfactant was determined for each individual master mix.  The enzymes 
suspended in storage buffers contain stabilizers.  It was observed that the droplets with 
enzyme solutions were easily dispensed and manipulated on a cartridge without any 
additional surfactant.  Thus, the assembly master mix and PCR master mix did not 
contain Tween 20.  The final concentrations of reagents in the assembly reaction were 1X 
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isothermal (iso) buffer, 0.05 U/µL of Phusion polymerase, 4 U/µL DNA ligase, 0.08 
U/µL T5 exonuclease, and 250 nM oligos.   
Prior to mixing with assembly reagents, 1 µL of exonuclease was diluted by 10-fold 
in 8 µL of water and 1 µL of Buffer 4.  For the assembly experiments without 
exonuclease, T5 exonuclease was omitted.  Gibson assembly iso buffer was prepared as 6 
mL batch, and 500 µL aliquots were stored at –20 ⁰C.  The components of the buffer 
were 500 mM Tris-HCl (pH 7.5), 50 mM MgCl2, 1 mM of each deoxynucleotide, 50 mM 
of DTT, 25% of PEG-8000, and 5 mM of NAD [38].  The amplification reaction was 
composed of 1X HF detergent-free buffer, 0.25 mM of dNTPs, 0.4 µM of each forward 
and reverse primers, 0.1 U/µL of Phusion polymerase, 0.625 mM PEG 8000, and 0.5 mM 
MgCl2. 
4.3.2. Optimization of Dilution Prior to Amplification and Determination of PCR 
Conditions 
Additional experiments were performed to determine the optimum dilution of the 
assembly product before PCR.  This step of the assembly process was very important 
because the dilution allowed the removal of unreacted oligos, misassembled sequences, 
and Gibson assembly reagents before the amplification.  The experiments shown in  
Table 6 were performed to find the maximum possible dilution.  Also, the amplification 
of the assembly product was optimized.   
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Table 6.  Experimental design to study optimization of the microfluidic DNA assembly 
process.  
Run 
No. 
Oligo 
concentration 
Dilution rate 
before PCR 
PCR conditions (final concentration) 
6 
1 
250 nM 
 
2-fold 
0.1 U/µL Phusion 
 
4-fold 
8-fold 
16-fold 
32-fold 
64-fold 
128-fold 
2 50 nM 
8-fold 
0.02 U/µL Phusion 
0.1 U/µL Phusion 
16-fold 
0.02 U/µL Phusion, 0.5 mM MgCl2, 0.625 mM 
PEG  
0.1 U/µL Phusion, 0.5 mM MgCl2, 0.625 mM 
PEG 
In Run 1, the assembly products were diluted from 2-fold to 128-fold and amplified 
by PCR using the baseline microfluidic protocol shown in Table 2.   
The results of Run 1 demonstrated that the dilution of the assembly product over    
16-fold did not produce the correct assembly product.  Thus, the 8-fold and 16-fold 
dilutions were tested in Run 2.  The reactions were carried out to determine if the same 
dilution held for the 50 nM oligo assembly.  Additionally, four different PCR conditions 
were tested to see which combination gave the best amplification of the assembly 
products.  The first reaction had the same reagents as a standard benchtop PCR, and a 
second contained a 5-fold increase in the amount of Phusion.  The third and fourth 
reaction were supplemented with 0.5 mM MgCl2 and 0.625 mM of PEG 8000, and the 
amount of Phusion was 1X and 5X, respectively.  
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4.3.3 Automation Program for Microfluidic DNA Assembly   
The first step of the process was setting up the device with an electrowetting voltage 
of 300 V and a frequency of 30 Hz.  Then, the temperature in the assembly area was set 
to 50 ⁰C.  Next, the droplets containing oligos were dispensed.  The droplets were 
transported to a waiting area where they were held while another dispenser generated 
Gibson master mix droplets.  The assembly droplets were merged with the oligo droplets 
and brought to the assembly area where they were incubated for 15-60 min at 50 ⁰C.  To 
ensure adequate mixing, the droplets were shuttled up and down.  When the reaction was 
finished, the assembly droplets were merged with the 2X PCR droplets, so the total 
volume of each droplet became 1.2 µL.  The polymerase chain reaction was performed as 
described in Section 4.2.3.  After amplification, the droplets were moved to the collection 
reservoirs and recovered from the cartridge manually.  For the experiments described in 
Table 6, a dilution step before PCR was added to the program.  To perform dilutions, a 
dispenser containing DI water and 0.05% Tween 20 generated double droplets.  Then, the 
droplets were merged with the assembly droplets, mixed, and split into two equal size 
droplets.  This step was iterated to achieve the dilutions shown in Table 6.   
When assembly time was variable, for example in Run 1 in Table 5, 2X droplets 
containing both the oligos and Gibson assembly reagents were held in a waiting area, and 
two droplets were moved to the assembly incubation zone in 15 min increments.  This 
way, each condition was tested twice in two different experimental droplets.   
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4.4 Procedures for development of the Automation Protocol for Gibson Assembly 
with Two CorrectASE™ Treatments 
This section describes the steps in the development and validation of automation 
protocols for Gibson assembly with two rounds of error correction.  The following 
objectives were investigated at this stage of the study. 
 Determine temperature settings and droplet routing procedure for microfluidic 
error correction. 
 
 Combine Gibson assembly, PCR, and enzymatic error correction in a single 
automation program. 
 
 Develop experimental protocols for Gibson assembly of 12 oligos with two 
CorrectASE™ treatments. 
 
 Test DNA assembly with error correction protocols on the Mondrian™ SP device. 
4.4.1 Determination of Temperature Settings for Error Correction Experiments 
Enzymatic error correction experiments were conducted with a commercial enzyme 
CorrectASE™.  The protocol provided by the manufacturer included four steps: 
denaturation, annealing, error correction reaction with the enzyme, and PCR 
amplification.  As shown in Figure 20, to expose the errors in the DNA sequence, double 
strands have to be separated and reannealed.  When the strands come together, they form 
heteroduplexes at mismatch sites that can be identified and removed by the error 
correction enzyme.  During the denaturation step, DNA is diluted to 20-25 ng/µL in 1X 
CorrectASE™ buffer to a final volume of 50 µL and incubated at 98 ⁰C for 2 min, 4 ⁰C 
for 5 min, and 37 ⁰C for 5 min.  Then, 10 µL of DNA are mixed with 1 µL of 
CorrectASE™ and incubated at 25 ⁰C for an hour.  After error correction, DNA is PCR 
amplified.  
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In order to meet denature/annealing temperature requirements, several empty 
cartridge tests were conducted.  A program was created in which heating and cooling of 
the cartridge was monitored.  It was important to determine how quickly the denaturation 
area of the cartridge heated up to 98 ⁰C, and how far heat extended throughout the 
denature/annealing zones.  To perform this experiment, heater bar #1 situated under the 
denaturation area was set to 98 ⁰C.  To create conditions for annealing, two more heater 
bars, #2 and #3, were set to 37 ⁰C and 25 ⁰C, respectively.  The heater #1 was shut down 
after 11 min, and the heater #2 was shut down after 20 min.  Afterwards, the cooler was 
activated, and the temperature was monitored for 79 min.  During the experiment the 
temperatures in four zones were checked and recorded every 60 s.  The experiment 
showed that the heat spread rapidly and increased the temperature above the desired 
temperature of 37 ⁰C and 25 ⁰C in the annealing area.  The denature/anneal cycle was 
modified by decreasing temperature set points, and turning on and off the heaters at 
different times.  Two denature/anneal procedures were developed.  
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Figure 20.  Error correction process with CorrectASE™ enzyme. 
The first procedure was similar to the benchtop protocol.  It was difficult to move the 
droplets at temperatures below 10 ⁰C, so the droplets were incubated at 98 ⁰C for 2 min, 
6 min at 25 ⁰C, and 5 min at 37 ⁰C.  In this experiment, Peltier cooler was set to 4 ⁰C 
prior to the error correction pretreatment.  The first heater bar was turned on for 9 min 
with a setting point of 111 ⁰C to obtain 98 ⁰C in the denature area.  The next heater was 
turned on with 5 min delay after the first one was shut down.  This heater was set to 33.9 
⁰C to obtain 37 ⁰C and 25 ⁰C zones in the annealing area.  The heater was kept on for 6 
min.  When the annealing process was done, the lanes were cooled down by the Peltier 
cooler for 5 min.  The lanes were brought to a room temperature in 12 min.  The error 
correction area was heated up to 25 ⁰C by setting the heater to 24.1 ⁰C.  
In a second procedure, a modified denature/anneal cycle was developed.  It was 
hypothesized that repeating the cycle four times should be sufficient for separation and 
reannealing of DNA strands.  In this cycle, the droplets were incubated at 98 ⁰C for 1 
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min, 25-30 ⁰C for 1 min, and 37 ⁰C for 1 min.  To ensure that the lanes did not overheat, 
the cooler was set to 4 ⁰C prior to the denature/anneal stage.  The droplets were moved at 
a speed of 1 s/electrode.  The actuation voltage was changed to 90 V when the samples 
were transported through the high temperature area.  In the annealing area, the droplets 
were pulsed to provide mixing.  The heater for the denaturation zone was set to 111 ⁰C to 
achieve an effective temperature in the droplet of 98 ⁰C.  After the heater had switched 
off, the lanes were cooled down for 10 min by the cooler and for 20 min by ambient 
conditions.  The error correction zone was set to 24.1 ⁰C to maintain 25 ⁰C in the 
incubation area.   
4.4.2 Automation Program for Microfluidic DNA Assembly with Error Correction  
To perform gene assembly and error correction experiments, the assembly automation 
program described in Section 4.3.3, the PCR program shown in Section 4.2.3, and the 
error correction procedures from Section 4.4.1 were combined into one program.  Figure 
21 demonstrates the order of gene synthesis reactions and liquid handling operations that 
were performed on the microfluidic device.  The gene synthesis process was composed of 
six consecutive enzymatic reactions: oligonucleotide assembly, first amplification 
(PCR1), first error correction (EC1), second amplification (PCR2), second error 
correction (EC2), third amplification (PCR3).  The oligo assembly was carried in the 
“Assembly” block.  Amplification reactions occurred in blocks “PCR1”, “PCR2”, and 
“PCR3”.  The incubation with CorrectASE™ was performed in “EC1” and “EC2” 
blocks.  To pretreat DNA prior to error correction, double stranded DNA was separated 
and reannealed in blocks “EC1 denature/anneal” and “EC2 denature/anneal”.  Multiple 
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dilution steps were included between enzymatic reactions.  The “Dilution before PCR1” 
block was used optionally.  In the experiments where the dilution rate before PCR1 was 
2-fold, no dilution was necessary.  By merging assembly products with PCR droplets, 
assembly constructs were diluted by half.  “Dilute before PCR2” and “Dilute before PCR 
3” blocks were made as loops, so it was convenient to change dilution rates.  The 
“Collect droplets on lanes 1,2” block was responsible for collection of two droplets of 
amplified assembly products.  The “Collect droplets on lanes 3,4,5” block retrieved three 
amplified samples after EC1, and the “Collect droplets on lanes 6,7,8” recovered three 
amplified EC2 droplets.  
 
 
Figure 21.  Automation program for microfluidic DNA assembly with two rounds of 
error correction. 
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4.4.3 Experimental Protocols for Microfluidic DNA Assembly with Error Correction  
Based on the experiments described in Sections 4.2 and 4.3 two DNA assembly with 
error correction protocols were developed.  The protocols consisted of six consecutive 
enzymatic reactions.  The process started with Gibson assembly that was carried for 60 
minutes.  Then, the assembly products were amplified in 30 PCR cycles.  Next, DNA was 
treated with CorrectASE™ for 60 min.  The error correction products were amplified in a 
second PCR and error corrected for the second time.  Finally, the second error correction 
products were amplified in a third PCR.  Table 7 compares two microfluidic and a 
benchtop protocols used in this study.   
Table 7.  Steps of DNA assembly and error correction process. 
    Benchtop    Microfluidic 
  protocol 1   
  Microfluidic 
  protocol 2 
  Assembly reaction conditions   50 nM oligos    250 nM oligos    50 nM oligos 
  Dilution before PCR1    20-fold  
  2-fold  
  16-fold 
  16-fold 
  Dilution before EC1 
  denature/anneal  
  5-fold    32-fold  
  4-fold 
  8-fold 
  16-fold 
  Dilution before EC2 
  denature/anneal  
  5-fold   16-fold   4-fold 
  Dilution before PCR2/PCR3   25-fold    16-fold    16-fold 
  Denature/anneal procedure 
  2 min – 98 ⁰C 
  5 min – 4 ⁰C 
  5 min – 37 ⁰C 
  2 min – 98 ⁰C 
  5 min – 25 ⁰C 
  5 min – 37 ⁰C 
  4 cycles: 
  1 min – 98 ⁰C 
  1 min – 25 ⁰C 
  1 min – 37 ⁰C 
In the first protocol, 250 nM oligos were used for assembly.  The dilutions rates 
before amplification and error correction pretreatments were determined by trial and 
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error.  The second protocol was made to repeat reaction conditions and dilution rates 
similar to the benchtop protocol.  The procedures for DNA assembly and error correction 
with CorrectASE ™ were obtained from the J. Craig Venter Institute.  In protocol 2, the 
concentration of oligos was 50 nM, and the dilution rates were modified from the 
benchtop protocol.  Since merging and splitting droplets on a DMF cartridge could be 
performed in 2-fold increments, dilutions on the microfluidic device were rounded to   
16-fold before PCR1 and 4-fold prior to error correction.   
4.4.4 Experimental Matrices for Validation of DNA Assembly and Error Correction 
Protocols on the DMF 
Several experiments were performed utilizing both microfluidic protocols described 
in Table 7.  The experimental runs are shown in Table 8.  Runs 1-3 were performed using 
protocol 1.  According to this protocol, the final concentration of oligos in the assembly 
reaction was 250 nM.  After assembly, the product was diluted by either 2 or 16-fold.  
Two different denature/anneal procedures were tested.  Since the PCR product after the 
assembly step had additional MgCl2 and PEG 8000 that originated from Gibson iso 
buffer, two PCR master mixes were prepared.  The master mix for amplification of error 
correction products by PCR2 and PCR3 provided 0.625 mM PEG 8000 and 0.5 mM 
MgCl2, whereas master mix for PCR1 did not have any additional reagents.   
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Table 8.  Experimental matrix for microfluidic protocol 1. 
Run 
No. 
Dilution before PCR1 Denature/anneal procedure before EC1/EC2 
1 2-fold 2 min – 98 ⁰C, 6 min – 25 ⁰C, 5 min – 37 ⁰C 
2 2-fold 4 cycles:1 min – 98 ⁰C,1 min – 25 ⁰C, 1 min – 37 ⁰C 
3 16-fold 4 cycles:1 min – 98 ⁰C,1 min – 25 ⁰C, 1 min – 37 ⁰C 
A second protocol was utilized in Runs 1-4 in Table 9.  In Run 1, the conditions 
similar to the benchtop protocol were tested.  The amount of polymerase was increased 
twice to account for surface effects in the microfluidic device.  In Runs 2-4, amplification 
reactions were performed with additional polymerase, MgCl2, and PEG 8000 to ensure 
consistent amplification in all droplets.  Also, 4, 8, and 16-fold dilutions of the assembly 
product were tested. 
Table 9.  Experimental matrix for microfluidic protocol 2. 
Run 
No. 
PCR1 conditions 
(final concentration) 
PCR2/PCR3 conditions 
(final concentration) 
Dilution before EC1 
denature/anneal 
1 0.02 U/µL Phusion 
0.02 U/µL of Phusion 
0.5 mM of MgCl2 
0.625 mM of PEG 
4-fold 
2 
0.1 U/µL of Phusion 
0.5 mM of MgCl2 
0.625 mM of PEG 
0.1 U/µL of Phusion 
0.5 mM of MgCl2 
0.625 mM of PEG 
4-fold 
3 
0.1 U/µL of Phusion 
0.5 mM of MgCl2 
0.625 mM of PEG 
0.1 U/µL of Phusion 
0.5 mM of MgCl2 
0.625 mM of PEG 
8-fold 
4 
0.1 U/µL of Phusion 
0.5 mM of MgCl2 
0.625 mM of PEG 
0.1 U/µL of Phusion 
0.5 mM of MgCl2 
0.625 mM of PEG 
16-fold 
To perform experiments described in Tables 8 and 9, 10 different master mixes were 
prepared, which are shown in Appendix B.  The master mixes contained double amounts 
of reagents to obtain 1X concentration after the equal size droplets were merged.  The 
 58 
 
reagents were loaded on a DMF cartridge into dedicated dispensers prescribed by the 
automation program.  All master mixes except CorrectASE™ were loaded on the 
cartridge at the beginning of the process.  To ensure that the enzyme stayed active and 
fresh, CorrectASE™ was loaded in a dispenser three minutes before it was to be used by 
the program.  At the end of the process all droplets were collected in 20 µL of 0.05% 
Tween 20 solutions and retrieved from the device manually.  The samples were analyzed 
on a 2% agarose gel and prepared for cloning into a vector, transformation into E. coli, 
and DNA sequencing.  
4.5 Data Analysis 
4.5.1 Preparation of Samples for Sanger Sequencing 
A comprehensive list of materials used for sample preparation is shown in Appendix 
C.  Samples recovered from Lanes 1 and 2, 3-5, and 6-8, which corresponded to 
assembly, EC1, and EC2 treatments, respectively, were pooled and analyzed by DNA gel 
electrophoresis.  The samples were mixed with 6X orange DNA loading dye (Thermo 
Fisher Scientific), loaded on a 2% agarose gel, and run against a 1 Kb plus DNA ladder 
(Invitrogen).  The indication of a successful experimental run was the presence of a 339 
bp band.  Next, DNA was prepared for Sanger sequencing.  The samples were purified 
using Agencourt AMPure XP SPRI magnetic beads (Beckman Coulter).  The ratio of 
magnetic beads to DNA was 0.9X.  One volume of DNA was diluted into 0.9 volume of 
the beads.  
Cleaned up DNA was cloned into pUC19 vector.  In order to prepare pUC19 for 
cloning, it was amplified with pUC-049 cloning-R and pUC-049 cloning-F primers (IDT 
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DNA).  Thermocycler settings as well as regents are listed in Appendix D.  To remove 
template plasmid, the PCR product was digested with DpnI restriction enzyme at 37 ⁰C 
for 24 hours.  The amplified and digested vector was cleaned with 0.9X SPRI beads.  
Cloning of DNA fragments into pUC19 was done using Gibson assembly method.  
The concentration of vector and inserts were measured on the Nanodrop instrument and 
converted to fmol/µL.  The number of moles of insert had to be equal to or 2-3-fold 
greater than the moles of a vector.  The appropriate amounts of the vector and insert were 
mixed with 2X Gibson master mix and incubated at 50 ⁰C for 30 min [38].  Procedures 
for plasmid assembly are shown in Appendix D.  
The recombinant plasmids were used to transform E. coli.  Transformations were 
done by the electroporation method on the Gene Pulser II Porator electroporation system 
(Bio-Rad).  According to this method, 1 µL of plasmid and 20 µL of TransforMax 
EPI300 electrocompetent E. coli cells (Epicentre) were added in a 0.1 cm electroporation 
cuvette (Bio-Rad) and subjected to 1.8 kV.  The cells were recovered in 1 mL of LB 
broth and incubated in 37 ⁰C incubator for 60 min.  After the recovery, 15 µL of cells 
were plated on LB agar plates with Carbenicillin selection.  The transformed cells were 
left to form colonies overnight in a 37 ⁰C incubator.  
Resulting colonies were screened for the presence of the correct cloned insert.  
Screening was done by the colony PCR method with pUC5-’F and pUC3-’R primers.  
According to this method, 14 to 25 single colonies were selected from each plate and 
used as a template in the PCR reaction.  The details of the colony PCR reactions are 
shown in Appendix E.  The colony PCR products were analyzed on a 2% agarose gel.  
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The colonies that yielded a 419 bp band were selected to grow overnight cultures.  For 
each sample, at least 10 colonies were grown overnight in 5 mL of LB broth (Teknova) 
with Ampicillin (100 µg/mL, Sigma).  Overnight cultures were used to extract plasmids.  
Plasmid extraction was done using QIAprep Spin miniprep kit (Qiagen).  Extracted 
plasmids were send to Genewiz for Sanger sequencing with the M13F(-47) primer.  
4.5.2 Sequencing Data Analysis 
Sequencing data was analyzed using Benchling software available at 
www.benchling.com.  The output files were uploaded to the Benchling website and 
aligned with the original template sequence, shown in Appendix A, using Benchling’s 
sequence alignment tool.  Each sequence alignment was inspected for errors in the newly 
assembled sequence.  The errors were categorized in three groups: deletions, insertions, 
and substitutions.  The sequences that had misincorporated oligos were treated as 
“misassemblies”.  The error frequency per 1 kb (f) was calculated using Equation 2 [35]. 
f =
∑ xi×1000
n
i
n×li
                                                                                              Equation 2 
where xi is the number of errors in a single clone, n is the number of sequenced clones 
not including clones with misassemblies, and li is the length of a sequence in bases.  
Equation 3 was used to calculate the average percent of deletions (Pdel), substitutions 
(Psub), and insertions (Pin).  
Pdel/sub/in =
∑ xdel/sub/in
n
j
∑ xnj
×100%                                                                 Equation 3  
where xdel/sub/in is the sum of deletions, substitutions, and insertions found in sequenced 
clones, ∑ xnj  is the sum of all errors. 
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Standard deviation (SD) was calculated to demonstrate reproducibility of developed 
microfluidic protocols.  
SD = √
∑(X−X)2
m−1
×100%                                                                                 Equation 4 
where X is the value of dependent variable, X  is the mean value, and m is the number of 
runs.  
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CHAPTER FIVE 
RESULTS 
5.1 Results of Microfluidic PCR Experiments 
The main goal of microfluidic PCR experiments was to develop an automation 
protocol, which leads to reproducible DNA amplification on all lanes of the microfluidic 
cartridge.  Multiple experiments were done with the same reagents as with conventional 
benchtop PCR and a 5-fold increased amount of a polymerase enzyme.  No microfluidic 
PCR amplification was achieved using a synthetic DNA template that mimicked the 
Gibson assembly product.  However, it was shown that sufficient amplification was 
achieved if PCR was performed immediately after an actual Gibson assembly reaction.  
The hypothesis was that some of the components of the Gibson iso buffer were 
responsible for PCR improvement.  The results of the experimental runs described in 
Table 3 of Section 4.2.1 are shown in Figures 22 and 23.  
Figure 22 demonstrates that the additives drastically improved amplification 
efficiency.  Control samples, which contained 0.1 U/µL of Phusion polymerase, did not 
show any bands on the agarose gel.  On the other hand, PCR suplemented with the iso 
buffer resulted in the desired 339 bp bands.  The reactions that were only supplemented 
with polymerase had variable band intensities.  Sample to sample variation for reactions 
supplemented only with Phusion polymerase suggested that the iso buffer was 
responsible for the PCR boost, which agrees with the hypothesis.  
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Figure 22.  Polymerase chain reaction with the iso buffer and Phusion additives. 
Furthermore, amplification was carried out with individual components of the iso 
buffer.  Only the samples with the PEG 8000 additive were amplified (data not shown).  
This experiment demonstrated that the addition of PEG 8000 increased amplification, but 
the reaction was not as efficient as with the complete iso buffer.  
Figure 23 shows that the combination of 1.25 mM PEG 8000 and 1 mM MgCl2 
showed comparable band intensity as the iso buffer.  This result demonstrated that 
microfludic PCR carried with the excess Phusion must be supplemented with additional 
MgCl2 and PEG 8000 for successful amplification of DNA on the microfludic device.  
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Figure 23.  Polymerase chain reaction with two components of the iso buffer. 
5.2  Reduction of Adsorption of Phusion Polymerase on the Microfluidic Surface 
Even though it was shown that amplification was successful, the issue of polymerase 
adsorption was not solved.  The main consequences of adsorption were droplet 
movement failure and inability to recover all samples from the microfluidic device.  To 
minimize protein adsorption on the microfluidic surface, different methods discussed in 
the literature review were tested.  The following results are based on the experiments 
shown in Table 4. 
The addition of BSA to the PCR reaction mixture resulted in complete failure of a 
droplet movement.  The droplets did not spread on the activated electrodes.  The 
hypothesis for this experiment was that BSA would bind to the surface instead of 
Phusion.  It has been shown that the BSA gives the same effect as a 5-fold increase of 
polymerase [29].  However, BSA has a high surface activity and make the droplets stick 
to the surface [40].  In addition, the negatively charged protein molecule interacts with 
the positively charged surface when a voltage is applied [27].  Thus, for the Mondrian™ 
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SP microfluidic device, BSA had a negative effect on droplets’ movement.  A protein 
pre-coating might be effective for continuous flow microfluidic channels, but it does not 
work for electrowetting based digital microfluidics. 
As seen in Figure 24, by increasing polymerase concentration, the intensity of the 
bands on the agarose gel becomes brighter.  The results demonstrated that the adsorption 
of polymerase did not change with the addition of 0.02% w/v Pluronic F68.  The highest 
amplification yield was achieved with 0.14 U/µL of Phusion, which is a 7-fold increase 
of the enzyme over standard benchtop PCR conditions.  Since the sample that had the 
highest concentration of Phusion did not show the brightest band, and the sample with the 
lowest concentration showed a very faint band, there is a possibility that the Pluronic 
slightly reduced the adsorption.  A subsequent experiment with four different 
concentrations of Pluronic and 0.02 U/µL of Phusion resulted in the loss of droplets from 
all lanes.  This result suggested that the enzyme was adsorbed on the surface, and 
pluronic F68 is not effective in the reduction of biofouling for DMF devices.  
 
Figure 24.  Microfluidic PCR with 0.02% w/v Pluronic F68 and variable Phusion 
concentration. 
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Another approach to the reduction of surface interactions was pre-coating the 
microfluidic surface with 10% w/v PEG 6000, PEG 4000, and PEG 3350 solutions prior 
to the PCR.  The results of this experiment demonstrated no improvement in PCR yield, 
and no DNA bands appeared on the agarose gel (data not shown).  Figure 25 shows that 
pre-coating of the surface with PEG 8000 improved PCR yield.  Amplification was 
achieved with the benchtop concentration of Phusion (0.02 U/µL) and a 4-fold increase of 
the enzyme (0.08 U/µL).  However, the intensity of the bands varied in samples with the 
same reaction conditions.  One of the possible reasons was that some parts of the 
microfluidic surface were not forming interactions with the polymer, and the enzyme was 
released from the aqueous droplet.  Alternatively, the absence of a band for the 0.2 U/µL 
Phusion sample could suggest that the reaction had an excess of the enzyme, which 
resulted in amplification failure.  The Phusion polymerase user manual says that the 
amount of enzyme should not exceed 0.04 U/µL.  Thus, if a 10-fold amount of the 
enzyme (0.2 U/µL) was used in a benchtop experiment, DNA would not be amplified.  
Even though pre-coating with PEG 8000 reduced polymerase adsorption, it was still 
difficult to move samples through the “hot” denaturation zone.  The droplets were 
releasing microbubbles and were not spreading entirely on the activated electrodes.  
Some samples were lost during the experiment.  Thus, pre-passivation was not effective 
in improving droplet transport.  
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Figure 25.  Microfluidic PCR with 10% w/v PEG 8000 pre-coat. 
Successful amplification was achieved on all eight lanes when the actuation voltage 
in the PCR cycle was reduced from 300 V to 90 V.  During the experiment the droplets 
were moving from the denaturation to the annealing/extension area without any 
complications.  The droplets were completely wetting energized electrodes, and no 
destruction of the oil/water interface was observed.   
5.3  Results of Microfluidic DNA Assembly 
The first group of experiments was conducted to identify the optimum time of 
reaction.  Figure 26 shows the image of agarose gel.  The bands for all tested times have 
similar brightness.  This means that the oligos were assembled in 15-60 min time period, 
and it is an acceptable range for the microfluidic DNA assembly. 
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Figure 26.  Microfluidic assembly at different times. 
As seen in Figure 27, T5 exonuclease is an essential reagent when 250 nM oligos are 
assembled.  Without the enzyme, the oligos did not form a double-stranded piece.  Figure 
27 (a) shows a smear instead of a single band.  On the other hand, the assembly products 
that were obtained in the presence of T5 exonuclease demonstrated the bands that were 
the right 339 bp size.  As shown in Figure 27 (b), the intensity of the bands did not vary 
from sample to sample, so it was concluded that for the 250 nM oligo assembly T5 
exonuclease is essential.   
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Figure 27.  Microfluidic assembly of 250 nM oligos for 60 min.  (a) Assembly without 
T5 exonuclease.  (b) Assembly with T5 exonuclease. 
Dilution of the assembly product prior to the amplification is an additional step that 
should be included in a microfluidic Gibson assembly protocol.  Since the goal was to 
assemble the product that had the minimum number of errors, it was important to remove 
unreacted oligos, oligo fragments, and misassemblies that were present at a low level 
before amplification.  As shown in Figure 28, dilution of the assembly constructs from 2-
fold to 16-fold resulted in comparable amounts of the PCR product.  However, 16-fold 
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was the maximum dilution rate that could be achieved before the PCR template was too 
diluted to amplify.  A dilution rate greater than 32-fold did not result in amplification of 
the assembly product.  Based on these results, it is better to keep the dilution of the 
assembly product no greater than 16-fold. 
 
Figure 28.  Dilution of the 50 nM oligo assembly product prior to PCR. 
Figure 29 illustrates the results of the Gibson assembly of 50 nM oligos that were 
diluted by either 8 or 16-fold and amplified at four different PCR conditions.  It could be 
concluded that both dilutions resulted in a similar amplification efficiency.  However, 
different PCR treatments led to different results.  The samples that had 0.02 U/µL of 
Phusion along with MgCl2 and PEG were not amplified.  On the other hand, PCR with 
0.1 U/µL of Phusion, MgCl2 and PEG demonstrated the largest amplification yield.  The 
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samples amplified with 0.1 U/µL of Phusion had brighter bands than samples amplified 
with 0.02 U/µL of the enzyme.  Also, the intensity of bands was not consistent for 0.02 
U/µL Phusion.  
 
Figure 29.  Dilution of assembly product by 8-fold and 16-fold followed by amplification 
at four different conditions: 0.1 U/µL Phusion; 0.02 U/µL Phusion; 0.1 U/µL Phusion, 
0.625 mM PEG, and 0.5 mM MgCl2; 0.02 U/µL Phusion, 0.625 mM PEG, and 0.5 mM 
MgCl2. 
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5.4 Temperature Settings for Error Correction Experiments 
Figure 30 compares temperature variation in the denaturation, annealing, and EC 
incubation zones when all heaters were turned on simultaneously.  The temperatures were 
set to maintain 95-98 ⁰C, 37 ⁰C, and 25 ⁰C in the denature, annealing, and EC zones, 
respectively.  As seen in Figure 30 (a), it took about 6 min to achieve temperatures 
suitable for separation of dsDNA.  When the heater was on, the temperature in the 
denaturation zone was fluctuating between 92 ⁰C and 96 ⁰C.  The temperature in the 
annealing area, which was supposed to be at 37 ⁰C, increased to 43-51 ⁰C.   
The annealing 25 ⁰C area drifted to 37-40 ⁰C.  As seen in Figure 30 (b), the cartridge 
cooled down in 25 min, and the temperature settled to 28 ⁰C.  Thus, the results of this test 
demonstrated that the heat in the cartridge spreads rapidly, and it takes about 25 min to 
cool down.  To reduce overheating of annealing and EC zones, the denaturation zone 
heater should be shut down when it is not needed.  Additionally, the temperature in those 
areas should be regulated by reducing temperature set points and cooled down by the 
adjacent Peltier cooler.  
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Figure 30.  Variation of temperatures on the DMF cartridge.  (a) During EC 
denature/anneal pretreatment.  (b) Error correction incubation. 
Figure 31 shows temperature variations in the denaturation, annealing, and cooling 
zones for two denature/anneal procedures.  In the first procedure shown in Figure 31 (a), 
DNA samples were kept at 95-98 ⁰C for 2 min before they were moved to the area 
between 25 ⁰C zone and the cooling zone and incubated for 6 min.  Next, the samples 
were transported to 37 ⁰C where they were annealing for 5 min.  By setting the 
denaturation zone to a higher temperature, 98 ⁰C was achieved.  By setting the 37 ⁰C 
zone heater to a lower set point just before the annealing step, the cartridge could 
maintain this zone at the prescribed temperature.  Even though the heater under 25 ⁰C 
zone was not activated, this area of the cartridge was overheated by the heat transferred 
from the adjacent zones.  To solve this issue, the droplets were moved next to the cooling 
area.  It was not possible to determine the temperature in the area between these two 
zones.  However, the purpose of the annealing step is a gradual reduction of temperature, 
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so single strands can form double strands.  Since the temperature in cooling zone was 
about 7 ⁰C, the temperature gradient for annealing was established.   
 
Figure 31.  Average variation of temperatures during EC denature/anneal treatments.  (a) 
2 min at 98 ⁰C, 6 min at 37 ⁰C, and 5 min at 25 ⁰C.  (b) 4 cycles: 1 min at 98 ⁰C, 1 min at 
37 ⁰C, and 1 min at 25 ⁰C. 
Figure 31 (b) shows the temperature distribution for a modified denature/anneal 
procedure.  In this procedure, the denature and annealing steps were repeated four times.  
The droplets were incubated at 98 ⁰C, 25 ⁰C, and 37 ⁰C for a minute.  To establish the 
temperature gradient on a cartridge, only the 98 ⁰C heater and Peltier cooler were 
activated.  Like in the first procedure, the 25 ⁰C zone was set next to the cooling area.  To 
keep the samples at 37 ⁰C during the first two cycles, the droplets were incubated 
between the 25 ⁰C and 37 ⁰C areas.  Because the heat from the denaturation zone was 
spreading and raising the temperature of the DMF cartridge, in the last two cycles, the 
samples were transported to the 25 ⁰C zone.  
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Figure 32 shows temperature variation of the EC zone during CorrectASE™ 
incubation.  Prior to the denaturation, the cartridge was cooled down by Peltier element 
for 5 min.  Since the temperatures lower than 10 ⁰C affect a surface tension of aqueous 
solutions as well as the properties of surfactants, the cartridge was allowed to equilibrate 
to the ambient temperature.  The denaturation area was set to 24.1 ⁰C to maintain the 
optimum reaction conditions.  As seen in Figure 32, the temperature was rapidly raised to 
25 ⁰C and maintained at this setting point for 60 min   
 
 
Figure 32.  Average temperature variation during CorrectASE™ incubation. 
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5.5 Sanger Sequencing Results of Assembly Samples 
To investigate if the concentration of oligos in the assembly reaction could influence 
the fidelity of assembly constructs, two sets of samples obtained by the assembly of 50 
nM or 250 nM oligos were sequenced.  The details about individual runs can be found in 
Appendix F.  Figure 33 demonstrates the average error rate from five separate runs for 
each oligo concentration.  It was determined that the average error rate for 250 nM and 
50 nM oligos was 3.15 errors/kb and 2.94 errors/kb, respectively.  The runs with 250 nM 
oligos had a standard deviation of 0.36 errors/kb and 50 nM oligos of 1.05 errors/kb.  
 
Figure 33.  Average error frequency for sequences assembled from 250 nM and 50 nM 
oligos. 
According to Table 10, single-base deletions comprised the bulk of errors.  There was 
no preference for errors to occur between A/T or C/G bases.  Both sets of samples had 
comparable percentages of deletions and the same amount of multiple-base deletions.  
The assembly of 50 nM oligos resulted in 13.1% insertions and 4.3% substitutions, 
whereas 250 nM assembly had 14.3% substitutions and 6.1% of insertions.  
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Table 10.  Error analysis of assembly constructs based on Sanger sequencing. 
 
250 nM oligos 
assembly 
50 nM oligos  
assembly 
Error type 
Deletion (total) 39 38 
G/C 18 15 
A/T 20 21 
Multiple-base deletion 2 2 
Insertion (total)  3 6 
G/C 2 3 
A/T 1 1 
Multiple-base insertion 0 2 
Substitution (total) 7 2 
A/T to G/C 1 0 
G/C to A/T 2 0 
G/C to C/G 2 0 
G/C to to T/A 0 1 
AT/ to C/G 1 0 
A/T to T/A 1 1 
Total errors 49 46 
Number of sequenced bases 15594 15594 
Average Error frequency (errors/kb) 3.15 2.94 
Standard deviation (errors/kb) 0.36 1.05 
Total clones without misassemblies 46 46 
Number of clones with misassemblies 2 3 
Percent of deletions 79.6% 82.6% 
Percent of insertions 6.1% 13.1% 
Percent of substitutions  14.3% 4.3% 
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5.6 Sanger Sequencing Results for Gibson Assembly with Error Correction for 
Protocol 1  
The results of experiments discussed in this section were obtained using the 
automation protocol 1 shown in Table 7 in Section 4.4.4.  Figure 34 represents the results 
of experimental runs described in Table 8.  In these experiments, the concentration of 
oligos in all runs was 250 nM.  Runs 1 and 2, shown in Figure 34 (a) and 34 (b), 
respectively, were performed to compare two denature/anneal procedures.  The 
experiment also determined the influence of dilution of the assembly product prior to 
PCR1 on the error reduction.  The results of a 2-fold dilution are shown in Figures 34 (a) 
and 34 (b), and the results of a 16-fold dilution are shown in Figure 34 (c).  
As seen in Figure 34 (b), only Run 3 demonstrated an error decrease with each 
CorrectASE™ treatment.  In this experiment, the assembly products were diluted by      
2-fold before PCR1, and the modified 4-cycle denature/anneal procedure was used in the 
automation program.  The error frequency was reduced from 3.28 errors/kb to 1.31 
errors/kb after two rounds of error correction.  The insertions were eliminated after the 
first error correction.  The error frequency of substitutions decreased after the first error 
correction and increased after the second error correction.  According to Figures 34 (a) 
and 34 (c), the error frequency increased after the first error correction and decreased 
after the second treatment.  However, the overall error frequency relative to an untreated 
assembly sample was not observed in Run 1.  
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Figure 34.  Error frequency of assembly samples followed by two rounds of error 
correction obtained using automation protocol 1.  (a) 2-fold dilution before PCR1, 
denature/anneal procedure: 2 min – 98 ⁰C, 5 min – 25 ⁰C, 5 min – 37 ⁰C.  (b) 2-fold 
dilution before PCR1, denature/anneal procedure 4 cycles: 1 min – 98⁰C, 1 min – 25 ⁰C, 1 
min – 37 ⁰C.  (c).  16-fold dilution before PCR1, denature/anneal procedure 4 cycles: 1 
min – 98 ⁰C, 1 min – 25 ⁰C, 1 min – 37 ⁰C. 
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The error analysis based on sequencing data of 88 clones shown in Table 11.  The 
number of error-free clones did not change for Run 1.  Thus, the error correction failed in 
this experiment.  In Run 2, seven clones out of nine were found to be error-free after the 
second error correction.  In contrast, three out of nine clones were correct in the untreated 
sample set.  This result indicates that the second error correction reaction was effective, 
but the first did not work.  In Run 3, the number of error-free clones increased, in this 
case from three to five.  Also, overall reduction of all types of errors was shown after the 
second CorrectASE™ treatment.   
Assembly constructs were diluted by 2-fold in Runs 1 and 3, and by 16-fold in Run 2. 
The dilution of the first error correction product was kept constant.  In Run 3, both error 
correction reactions were successful, and in Run 2, only the second error correction 
reaction was effective.  Thus, it was concluded that the dilution of assembly product does 
not affect the outcome of error correction reactions.  
Furthermore, Runs 2 and 3, had the modified denature/anneal cycle in which DNA 
molecules were denatured and reannealed four times instead of just one, as suggested by 
the CorrectASE™ manufacturer.  Since the enzyme could only recognize and remove the 
mismatch if the heteroduplexes were formed, it is possible that the modified procedure 
created better conditions for formation of heteroduplexes, and more errors were removed 
by CorrectASE™.   
Based on the results described above, the dilution of assembly product is not a critical 
factor that affects microfluidic error correction.  On the other hand, four cycles of 
denature/anneal were recognized to improve the error removal on the DMF cartridge.  
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Table 11.  Error analysis of assembly and error correction experiments using Protocol 1. 
 
Run 1 
(regular 
denature/anneal 
procedure, 
2-fold dilution before 
PCR1)  
Run 2 
(4-cycle 
denature/anneal 
procedure, 2-fold 
dilution before 
PCR1) 
Run 3 
(4-cycle 
denature/anneal 
procedure, 16-fold 
dilution before 
PCR1) 
 No EC EC1 EC2 No EC EC1 EC2 No EC EC1 EC2 
Error type Number of errors 
Deletion (total) 7 11 7 6 2 2 8 8 6 
Single-base deletion 
G/C 3 5 4 3 1 1 2 5 3 
A/T 3 5 2 3 5 1 6 2 3 
Multiple-base 
deletion 
1 1 1 0 0 0 0 1 0 
Insertion (total)  1 0 0 1 0 0 1 1 0 
Single-base insertion 
G/C 1 0 0 0 0 0 1 0 0 
A/T 0 0 0 1 0 0 0 1 0 
Substitution 
(total) 
1 1 1 3 1 2 2 3 1 
A/T to G/C 0 0 0 1 0 2 0 0 0 
G/C to A/T 0 1 0 1 0 0 1 2 0 
G/C to C/G 1 0 0 0 0 0 0 0 0 
G/C to to T/A 0 0 1 0 0 0 0 0 1 
AT/ to C/G 0 0 0 0 0 0 1 1 0 
A/T to T/A 0 0 0 1 1 0 0 0 0 
Total errors 9 12 8 10 7 4 11 12 7 
Sequenced 
bases 
3390 3390 3390 3051 3390 3051 3051 3051 3390 
Total clones 
without 
misassemblies 
10 10 10 9 10 9 9 9 10 
Total clones 
sequenced 
10 10 10 10 10 9 10 9 10 
Total of clones 
with correct 
sequences 
3 3 3 3 3 7 3 2 5 
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5.7 Sanger Sequencing Results for Gibson Assembly with Error Correction for 
Protocol 2 
Figures 35 and 36 demonstrate the results of the assembly and error correction 
experiments that were obtained using the Protocol 2 described in Section 4.4.4 and Table 
9.  According to this protocol, 50 nM oligos were used in the assembly reaction.  The 
assembly product was diluted by 16-fold before amplification to remove unreacted oligos 
and misassemblies.  The denature/anneal procedure was done in four cycles.   
A comprehensive analysis of error types found in 57 sequenced clones is shown in 
Table 12.  Figures 35 (a) and 35 (b) illustrate the results of a microfluidic experiment that 
was designed with conditions similar to a benchtop protocol.  Both microfluidic 
experiments were conducted on different days using the same reagents and automation 
program.  As seen in Figure 35 (a), the overall error frequency was reduced from 1.31 
errors/kb to 0.29 errors/kb, which is about a 4-fold decrease.  In this experiment, all 
substitutions and insertions were eliminated.  Conversely, a repeat of the same run, 
shown in Figure 35 (b), did not demonstrate the same level of error correction.  There 
was some reduction of the overall error frequency from 3.32 to 2.62 errors/kb.  The 
insertion errors were removed completely, but some substitutions appeared.  Figure 35 (c) 
shows the error frequency of samples obtained on a conventional thermocycler using a 
benchtop protocol shown in Table 7.  The error frequency was reduced from 2.16 to 0.29 
errors/kb, which was a 10-fold error reduction.   
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Figure 35.  Error frequency of untreated and treated with CorrectASE™ samples on a 
benchtop and on the DMF following protocol 2.  (a) PCR1 conditions –0.02 U/µL 
Phusion, PCR2/PCR3 conditions – 0.02 U/µL of Phusion, 0.5 mM of MgCl2, 0.625 mM 
of PEG.  (b) PCR 1 conditions – 0.02 U/µL of Phusion, 0.5 mM of MgCl2, 0.625 mM of 
PEG.  (c) a benchtop experiment. 
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Table 12.  Error analysis of benchtop and microfluidic assembly and error correction 
samples obtained using Protocol 2. 
 Run 1  Run 1 repeat Benchtop  
 No EC EC1 No EC EC1 No EC EC1 
Error type Number of errors 
Deletion (total) 2 1 6 7 5 1 
Single-base deletion       
G/C 1 0 3 3 2 1 
A/T 1 1 3 4 2 0 
Multiple base deletion 0 0 0 0 1 0 
Insertion (total)  1 0 3 0 1 0 
Single-base insertion       
G/C 1 0 1 0 1 0 
Multiple-base insertion 0 0 2 0 0 0 
Substitution (total) 1 0 0 1 1 0 
Transition        
A/T to G/C 0 0 0 0 1 0 
Transversion       
G/C to C/G 0 0 0 1 0 0 
A/T to T/A 1 0 0 0 0 0 
Total errors 4 1 9 8 7 1 
Sequenced bases 3051 3390 2712 3051 2712 3390 
Total clones without 
misassemblies 
9 10 8 9 9 10 
Total clones sequenced 10 10 9 9 9 10 
Total of clones with correct 
sequences 
5 9 2 2 3 9 
The results of these experiments demonstrated that the microfluidic error correction 
reaction was inconsistent.  It is possible that the reaction worked on some lanes and did 
not work on the others.  Since droplets were pooled before cloning and sequencing, this 
variability might have resulted in higher overall error rates.  Also, the first PCR 
amplification with only a 2-fold increase of Phusion polymerase might not have been 
effective in every droplet, which led to a lower amount of the PCR product.  If the 
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concentration of DNA was low in the error correction reaction, then the error removal 
process may not have been effective.  The CorrectASE™ manufacturer recommends 
using 25-50 nM DNA for efficient error reduction.  According to the protocol 2, the 
assembly product is diluted by 16-fold before PCR1.  It is likely that there was not 
enough Mg2+ and PEG 8000 from the assembly reaction to improve the PCR reaction 
efficiency.  Thus, it is important to perform PCR1 with a 5-fold increased Phusion 
polymerase along with PEG and Mg2+. 
To determine if dilution of the amplified assembly product could improve the 
effectiveness of the first error correction, three different dilutions were tested before the 
EC1 denature/anneal cycle.  The following results are based on the experimental runs 
shown in Table 9 in Section 4.4.4.  In these runs the assembly products were diluted by  
4-fold, 8-fold, and 16-fold.  The dilution before the second error correction was kept 
constant in all three experiments.  As seen in Figure 36 (a), a 4-fold dilution of the 
assembly product resulted in a gradual reduction of errors with each error correction 
reaction.  The error frequency was reduced by a 2-fold at the end of the process, 
substitutions were eliminated, but insertions were not removed.  As shown in Table 13, 
the number of error-free clones increased after the second CorrectASE™ treatment from 
0/10 to 5/11  
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Figure 36.  Error frequency of assembly samples followed by two rounds of error 
correction obtained using the automation protocol 2.  a) 4-fold dilution before EC1;         
b) 8-fold dilution before EC1; c) 16-fold dilution before EC1. 
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Table 13.  Error analysis assembly and error correction experiments using protocol 2. 
 Run 2 Run 3 Run 4 
 No EC EC1 EC2 No EC EC1 EC2 No EC EC1 
Error type Number of errors   
Deletion (total) 12 8 8 9 15 15 9 4 
Single-base deletion  
G/C 5 1 3 2 2 4 4 0 
A/T 7 5 3 5 12 10 5 2 
Multiple base 
deletion 
0 2 0 2 1 1 0 2 
Insertion (total)  1 1 1 1 0 1 0 0 
Single-base insertion         
G/C 1 1 0 0 0 1 0 0 
A/T 0 0 1 1 0 0 0 0 
Substitution (total) 1 0 0 0 1 0 0 1 
Transition          
G/C to A/T 0 0 0 0 1 0 0 0 
Transversion         
G/C to to T/A 1 0 0 0 0 0 0 1 
Total errors 14 9 7 10 16 16 9 5 
Sequenced bases 3600 2880 3600 3240 3600 4230 3600 3600 
Total clones without 
misassemblies 
10 8 10 9 10 12 10 10 
Total clones 
sequenced 
10 8 11 10 10 13 10 14 
Total of clones with 
correct sequences 
0 0 5 0 0 0 0 5 
The results of 8-fold dilution of the amplified assembly product are illustrated in 
Figure 36 (b).  In this run, no overall error correction after the second CorrectASE™ 
treatment was observed.  The error frequency of single base deletions was propagated 
after the first error correction.  Then, the error frequency was reduced after the second 
error correction relative to the first error correction step.  For each treatment, all 
sequenced clones had at least one error. 
 88 
 
Figure 36 (c) demonstrates the results of a 16-fold dilution before EC1 
denature/anneal.  For this experiment, only the assembly and EC1 samples were 
sequenced.  For this run, EC2 samples resulted in mostly misassembled products after 
cloning and colony PCR.  Only two out of 31 screened colonies had the right size 
product.  Based on the colony PCR, it was concluded that the EC2 step failed to yield the 
correct product.  On the contrary, EC1 demonstrated a 1.8-fold reduction of overall error 
frequency.  The number of singe-base deletions was reduced, but multiple-base deletions 
and transversion of G/C to T/A appeared in some sequences.  In Runs 3 and 4, five clones 
had completely correct sequences after the second error correction. 
The results shown in Figure 36 and Table 13 demonstrated that dilution of the 
assembly product before the EC/denature step is important.  However, it is not the only 
factor that leads to a successful error correction.  Both a 4-fold and 16-fold dilution runs 
were successful in error reduction and both had misassembled sequences after the error 
correction reactions.  Both samples demonstrated error reduction, but had an increased 
number of different size sequences in colony PCR screening that were considered as 
misassemblies (data not shown).  In these misassemblies, CorrectASE™ converted 
single-base error into large lesions.  It is evident that the enzyme cut the mismatch, but 
perhaps the larger lesions could be explained by hypothesizing that the problematic 
nucleotides were not removed by Phusion during subsequent amplification.  Those 
incorrect partially digested sequences of various sizes were subsequently PCR amplified, 
and the lesion sizes may have been increased as a result of errors during amplification.   
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Two out of four microfluidic error correction experiments using protocol 2 were 
successful in error reduction.  The lowest error frequency of 0.3 errors/kb was achieved, 
which was a 4-fold error reduction.  This result was in 3-10-fold range accepted for 
CorrectASE™ enzyme.  However, this result was not reproducible.  The degree of error 
reduction was varied from run to run.  It was concluded that error correction on the DMF 
was not reliable.  
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CHAPTER SIX 
DISCUSSION 
6.1 Microfluidic PCR with Phusion Polymerase 
The results of the microfluidic PCR experiments demonstrated that due to the high 
surface-to-volume ratio, reactions carried on the microfluidic device show a strong 
dependence on surface interactions.  Protein molecules can adsorb at the oil/water 
interface, which reduces the surface tension over time [27, 40].  Additionally, adsorption 
of a protein at the droplet interface could facilitate exposure of hydrophobic groups that 
may lead to change of a conformation and inactivation.  At high temperatures, the 
exposed hydrophobic groups of the protein could lead to protein denaturation.  
Adsorption and denaturation reduces the amount of available enzyme.  Therefore, the 
amplification reaction is inefficient due to the lack of the catalyst.  It has been shown in 
the literature that to achieve amplification efficiency similar to a benchtop PCR, the 
amount of polymerase must be increased up to a 10-fold [24, 25].  The results of PCR 
experiments presented here demonstrated that sufficient and repeatable PCR 
amplification could be achieved with a 5-fold increase of Phusion polymerase.  
The efficiency and specificity of PCR is affected by the Mg2+ concentration.  
Magnesium ions help the polymerase to fold in the active conformation.  Also, Mg2+ 
stabilizes dsDNA and increases the melting temperature (Tm) of primers.  Thus, it is 
crucial to have the correct amount of free magnesium.  If magnesium is scarce, the 
reaction will not proceed as efficiently.  It has been observed that the concentration of 
free magnesium is reduced because of precipitation on microfluidic surfaces, capture by 
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chelating agents present in reagents and storage buffers, and by binding to dNTPs [25].  
According to the Phusion manufacturer, the optimum concentration of MgCl2 is between 
0.5-1 mM.  The experimental results demonstrated that the addition of 0.5-1 mM of 
magnesium to 1.5 mM MgCl2, presented in Phusion HF buffer, improved polymerase 
activity, but this effect was inconsistent from lane to lane.  However, it was shown that 
the synergistic effect of magnesium and PEG 8000 created favorable conditions for PCR 
amplification.  
Polyethylene glycol (PEG) is recognized as a molecular crowding agent and 
frequently used as a PCR enhancer and an enzyme immobilization agent.  Molecular 
crowding creates the conditions similar to a natural cell environment in which the 
enzyme was evolved.  It was reported that macromolecular crowding affects the enzyme 
reaction kinetics by increasing the viscosity of a medium that in turn influences diffusion 
of reagents.  Also, the polymers preserve native protein conformation and facilitate 
binding to a substrate.  It has been shown that PEG 8000 stabilized polymerase at high 
temperatures [41, 42].  Since Phusion is a type of polymerase, it is possible that PEG 
8000 formed weak bonds with the enzyme and reduced hydrophobic interactions with the 
Teflon coating.  Additionally, PEG could have prevented hydrophobic groups from 
adsorbing to the oil/water interface of the DMF cartridge.  As a result, the activity of the 
enzyme was increased and amplification yield was improved [30].  Consequently, 
microfluidic PCR is affected by adsorption as well as the by interactions of reaction 
components with interfaces.  In order to achieve amplification on the DMF, the reaction 
must be carried out with the final concentration of 0.1 U/µL of Phusion (a 5-fold increase 
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relative to standard benchtop conditions), 0.5-1 mM of MgCl2, and 0.625-1.25 mM of 
PEG 8000.  
Multiple methods that have been reported in the literature to reduce biofouling in 
microfluidics were tested in this research.  The only method that improved PCR yield and 
transport of droplets was the reduction of the electrowetting voltage from 300 V to 90 V 
during PCR [20].  This result showed that at the lower voltage, the oil film between the 
aqueous droplet and the Teflon coated surface stayed intact and eliminated hydrophobic 
interactions between the polymerase and the surface.  According to Kleinert et al., the 
actuation voltage has a significant influence on the oil film [33].  At high actuation 
voltage when the droplet moves, the film becomes unstable, breaks down, and tiny oil 
droplets get trapped under the aqueous phase.  In addition, the excess of surfactant 
destabilizes the oil film.  Mohajeri and colleagues demonstrated that the critical micellar 
concentration of nonionic surfactants such as Tween 20 decreases with raising 
temperatures [34].  Thus, in the denaturation zone, less surfactant is necessary to reduce 
the surface tension.  If there is an excessive amount of surfactant, the oil film becomes 
unstable, and the adsorption of the protein occurs, which is further enhanced at high 
temperatures.  It is important to use lower voltage and minimize the amount of Tween 20 
to avoid loss of Phusion polymerase and subsequent droplet transport failure.  
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6.2 Microfluidic Gibson Assembly 
Microfluidic DNA assembly protocols developed in this work produce results similar 
to the results published in the literature.  It was reported by Gibson’s group and other 
researchers that DNA assembly reaction proceeds in 15-60 min [6, 23, 38].  The 
microfluidic DNA assembly protocol generated double-stranded DNA fragments from 
oligonucleotides in a similar 15-60 min time frame.  
The results of this study show that T5 exonuclease plays essential role in the 
assembly of 250 nM oligos.  The enzyme is known for its ability to chew back DNA 
overlaps from the 5’- end, but it also possesses endonuclease activity towards ssDNA.  It 
can degrade oligos into smaller fragments such as trimers, tetramers, and pentamers [43].  
Assembly of high concentration oligos should not be done without the exonuclease.  One 
of the advantages of assembly with exonuclease is that the enzyme could remove the 
overlaps, which were created by incorrect oligo alignment to prevent the appearance of 
misassemblies.  The results demonstrated that microfluidic assembly protocols work well 
in 50-250 oligo nM concentration range.  
To ensure that the excess of oligos and misassemblies are removed, the DMF 
assembly protocol has a dilution step after assembly and before PCR.  It was shown that 
the dilution by 16-fold was sufficient to keep enough template for further amplification.  
If the dilution step before PCR is employed, the amplification mix must contain 0.1 U/µL 
of Phusion, 0.625 mM PEG 8000, and 0.5 mM MgCl2.  The results of the experiments 
demonstrated that the 5-fold increase in Phusion concentration on its own did not provide 
the same yield of the assembly product in all experimental droplets.  On the other hand, 
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2-fold Phusion with Mg2+and PEG leads to production of different sized constructs.  As 
discussed in Section 6.1, the excess magnesium could lead to incorrect binding of 
primers, which may create errors in DNA sequence and amplification of misassemblies.  
Consequently, it is important to keep Mg2+at optimum concentration, if the assembly 
product is diluted before amplification.  
Error analysis of sequences assembled with 50 nM and 250 nM oligos demonstrated 
similar error rates.  This suggests that the concentration of oligos during assembly does 
not affect the fidelity of the resulting sequence.  Both DNA assembly methods 
demonstrated an error frequency in the 1-10 errors/kb range, which was similar to the 
values reported in the literature [7].  For instance, Saem et al. reported 1.9 errors/kb, 
Sequeira et al. reported 3.45 errors/kb, Kosuri et al. reported 4 errors/kb, and Yehezkel et 
al. reported 2.2 errors/kb [20, 36, 37, 39].  The analysis of error types demonstrated that 
the majority of errors belonged to single-base deletions with a small percentage of 
insertions and substitutions.  These results are comparable to 75.6% deletions, 2.2% 
insertions, and 22.2% substitutions, obtained by Sequeira et al. [39].  However, several 
clones in both data sets had misincorporated oligos.  The occurrence of misassemblies 
could have arisen from oligo misplacement and improper alignment as a consequence.  
This issue could be solved by improving the design of oligo sequences.  Since the 50 nM 
oligo data set had 1.5 times more clones with misassemblies, degradation of some oligos 
by T5 exonuclease could be the cause of misincorporation.  The results demonstrated that 
the Gibson assembly method performed on the DMF is efficient.  The error frequencies 
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for microfluidic synthesized sequences are in line with those found for benchtop DNA 
synthesis in the published literature.  
6.3 Microfluidic Error Correction with CorrectASE™ 
The results of the current work show that error correction with CorrectASE™ on the 
DMF is not yet reliable.   Since all experiments were run on different days using identical 
automation programs, there might be some issues with variability of equipment or 
microfluidic cartridges.  Additionally, the repeatability could be related to the size of the 
droplets that may be consistently generated.  Considering that reaction is carried in 1.2 
µL reactors that are incubated with CorrectASE™ for 60 min, volume differences and 
resulting concentration differences form merging droplets of slightly different volume 
could be a possible reason for error correction failure.  
Since the enzymes show the best activity at optimum reagent concentrations, 
evaporation of water will increase the concentration of salts making the enzyme less 
active.  Another possible reason is the adsorption of protein molecules on the oil/water 
interface.  According to Baldursdottir et al., protein molecules tend to aggregate on the 
oil/water interface in a multilayer.  The adsorption rate is affected by the molecular 
weight and a saturation concentration.  Large protein molecules tend to adsorb faster than 
small ones due to the large surface available for contact with the interface.  Also, 
hydrophobic proteins tend to adsorb more due to the hydrophobic interactions with 
hydrophobic substances [44].  If some of the protein molecules adsorb on the interface, 
hydrophobic and hydrophilic groups will rearrange, and it will cause the protein to 
change the conformation.  For proteins molecules, shape determines its function, so the 
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adsorption can lead to the loss of activity.   As a consequence, the concentration of 
enzyme is not going to be optimum, and the reaction will not proceed with the maximum 
yield.  
According to a patent describing the method of error removal using a mix of Surveyor 
nuclease and Exonuclease III enzymes, the Surveyor nuclease cuts the product near the 
site of a mismatch.  Then, the endonuclease digests the mismatched nucleotide in both 3’ 
to 5’ and 5’ to 3’ directions [38].  Then, the sequence is repaired by Phusion polymerase 
during subsequent PCR reactions.  Since CorrectASE™ is a proprietary blend, we do not 
know which enzymes it contains.  However, the mechanism of error removal by 
CorrectASE™ is very similar to Surveyor and Exonuclease III.  According to Invitrogen, 
the enzyme nicks both DNA strands at the 3’site.  Then, endonuclease removes the 
mismatch in a 3’ to 5’ direction.  In the experiments that demonstrated some amount of 
error correction, the number of sequences containing large insertions, which were 
categorized as misassemblies, increased with each CorrectASE™ treatment.  This 
suggests that the 3’ to 5’ exonuclease activity was not present or was not as effective on 
the DMF device.  It is likely that the activity of the enzyme is affected by either the 
adsorption of some protein molecules at the oil/water interface, microfluidic surface or by 
the interaction with the components carried through previous gene assembly steps. 
It was demonstrated in Section 5.2 that the presence of a molecular crowding agent 
such as PEG significantly increased the activity of Phusion polymerase.  According to 
Sasaki et al. the activity of DNase I to degrade supercoiled DNA and linear DNA was 
improved in the presence of 20% w/v PEG.  A kinetic analysis demonstrated that the rate 
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of the DNA cleavage reaction increased with the increasing of concentration of PEG.  
However, molecular crowding did not improve the activity of Exonuclease III and 
inhibited the activity of Exonuclease I [45].  Consequently, macromolecular crowding 
could be the reason why the CorrectASE™ activity is inconsistent on the microfluidic 
device, and future experiments will be needed to determine whether the addition of PEG 
will improve the performance of this step.  As we observed in the amplification of the 
assembly product with excess of magnesium relative to Phusion, the PCR product was 
amplified incorrectly.  Thus, the loss of polymerase specificity could also have 
contributed to a failure of error removal in the error correction experiments.  
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CHAPTER SEVEN 
CONCLUSIONS 
Automated DNA assembly and error correction protocols for the Mondrian™ SP 
digital microfluidic device by Illumina Inc. were developed in this thesis.  The process 
involved automation of the polymerase chain reaction, Gibson assembly of 12 
oligonucleotides, and enzymatic error correction reaction with CorrectASE™.  The final 
protocol consisted of the assembly of oligonucleotides, three PCRs, and two error 
correction reactions.   
The development of the microfluidic PCR protocol consisted of two major tasks.  The 
first task was to determine the optimum reagent concentrations for a consistent and 
repeatable DNA amplification.  It was shown that in order to achieve reliable 
amplification, the PCR reaction mix must contain an additional 0.5-1 mM MgCl2 over 
that required for bench top protocols, and 1.25 mM PEG 8000.  Magnesium is 
responsible for activation of the Phusion polymerase, and PEG 8000 preserves the 
enzyme’s structure and brings reagents into close proximity.   
The second task was minimization of adsorption of Phusion polymerase on the 
microfluidic surface.  The adsorption of Phusion was eliminated by a reduction of 
actuation voltage from 300 V to 90 V during thermocycling.  The lower voltage keeps 
stable the oil film under the droplet, which prevents adsorption at the liquid/solid 
interface.  The adsorption of the enzyme on the oil/water interface was also minimized by 
increasing the enzyme concentration by 5-fold. 
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The automation protocol for microfluidic DNA assembly consisted of the Gibson 
assembly reaction, dilution of the assembly product, and subsequent amplification of 
DNA constructs by PCR.  It was shown that the assembly times of 15-60 min gave the 
right size assembly product.  Additionally, a 16-fold dilution of the assembly products 
before PCR gave enough template for amplification and removed unreacted oligos and 
misassembled sequences.  It was determined that the concentration of oligonucleotides 
for successful assembly should be in 50-250 nM range.  The protocol was validated for 
50 nM and 250 nM oligo assembly by Sanger sequencing.  The sequencing results 
demonstrated that both oligo concentrations produce sequences with error frequencies 
about 3 error/kb, which falls in the 1-10 error/kb range reported in the literature.  The 
errors were categorized into deletions, substitutions, and insertions.  The majority of 
errors were single-base deletions.  
The Gibson assembly, PCR, and error correction reactions were combined in a single 
protocol.  To be able to monitor the changes after each step in the process, the amplified 
assembly, EC1, and EC2 products were Sanger sequenced.  The results of sequencing 
showed that the 4 cycles denature/anneal procedure for the DMF was shown to be better 
at forming heteroduplexes in a place of mismatches.  Dilution of the unamplified and 
amplified assembly products did not demonstrate a significant effect on the outcome of 
the error correction reaction.  Some samples from the experiments that showed a gradual 
error frequency reduction after each treatment were found to have large lesions at the 
beginning or the end of the sequence.  The occurrence of lesions could be due to 3’ to 5’ 
inactivity of CorrectASE™ related to surface chemistry of protein molecules under a 
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high surface-to-volume conditions or interactions with the reagents carried from previous 
gene synthesis steps.  It was concluded that microfluidic error correction with 
CorrectASE™ did not give repeatable results, and the inhibition of enzyme should be 
investigated in future studies. 
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CHAPTER EIGHT 
FUTURE STUDIES 
Automation of routine molecular biology reactions brings many benefits for 
scientists.  It reduces the cost of reagents and labor, eliminates human errors, and saves 
time-consuming steps such as pipetting, mixing reagents, and tube labeling.  In this study, 
a gene assembly protocol for digital microfluidics was developed.  It was shown that the 
protocol gives results comparable to conventional benchtop protocols.  However, the 
reduction of errors in synthetic genes on the DMF was inconsistent.  In future studies, the 
adsorption of CorrectASE™ on the oil/water interface should be investigated. 
Additionally, the effects of macromolecular crowding on CorrectASE™ activity should 
be tested by the addition of various polymer molecules.  The carryover of magnesium 
from error correction reaction to subsequent PCR should be investigated.  Error 
correction with CorrectASE™ should be compared to other enzymes such as Surveyor 
nuclease, Exonuclease III, and T7 Endonuclease I.  
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Appendix A: Materials  
 HA 049 sequence cloned in a plasmid DNA (prepared by the J. Craig Venter 
Institute) 
 
GAATTCGAGCTCGGTACCCGGCGGCCGCTTTGAGTCAGCCATCTCATGTT
CCTGTAGAATGAATCTGAACATGATTTGCTTGTTCCAGTGTAAGTCACATTCC
AGATTGTGTCTGGGAATATTTGGATTCTTTGGTAGGAACTAGAGGAACTAAA
GAGTGTTCTGAGTTCCTCTAAGTTTTCCACATTCCCAGGGTAACACGTTCCAT
TTACAGCTGATGGTCTTTCAACGATGTAGGACCATTCTCTTCCCCCCAACAAC
AGATCACAAGAAGGGTTACCATAGACAAGTCCTTCAATAGTGCATGTGTCGC
GGCCGCGATCCTCTAGAGTCGACCTG 
 
 Oligonucleotides 1 µM each (Integrated DNA Technologies).  Sequences are shown 
in Table 14 
 
 Tween 20 (Sigma Aldrich) 
 DNAse, RNAse-free UltraPure™ DI water (Invitrogen) 
 Phusion High-Fidelity (HF) DNA polymerase 2 U/µL (Thermo Fisher Scientific) 
 
 5X Phusion HF detergent-free buffer (Thermo Fisher Scientific) 
 Forward PCR primer: 100 µM Oligo HA 049-1 (IDT DNA):  
5’CAGGTCGACTCTAGAGGATCGCGGCCGCGACACATGCACTATTGA 
AGGACTT 
 
 Reverse primer: 100 µM Oligo HA 049-12 (IDT DNA): 
5’GAATTCGAGCTCGGTACCCGGCGGCCGCTTTGAGTCAGCCATCTCATGT
TCCT 
 
 100 mM deoxynucleotide kit (Thermo Fisher Scientific) 
 PEG 8000 (Sigma) 
 PEG 6000 (Sigma) 
 PEG 4000 (Sigma) 
 PEG 3350 (Sigma) 
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Table 14.  A list of oligonucleotide sequences. 
Oligo name Sequence 
Length 
(bases) 
HA 049-1 
CAGGTCGACTCTAGAGGATCGCGGCCGCGACACATG
CACTATTGAAGGACTT 
52 
HA 049-2 
AGATCACAAGAAGGGTTACCATAGACAAGTCCTTCA
ATAGTGCATGTGTCGC 
52 
HA 049-3 
GTCTATGGTAACCCTTCTTGTGATCTGTTGTTGGGGG
GAAGAGAATGGTCCT 
52 
HA 049-4 
TACAGCTGATGGTCTTTCAACGATGTAGGACCATTCT
CTTCCCCCCAACAAC 
52 
HA 049-5 
ACATCGTTGAAAGACCATCAGCTGTAAATGGAACGT
GTTACCCTGGGAATGT 
52 
HA 049-6 
GTGTTCTGAGTTCCTCTAAGTTTTCCACATTCCCAGG
GTAACACGTTCCATT 
52 
HA 049-7 
GGAAAACTTAGAGGAACTCAGAACACTCTTTAGTTC
CTCTAGTTCCTACCAA 
52 
HA 049-8 
ATTGTGTCTGGGAATATTTGGATTCTTTGGTAGGAAC
TAGAGGAACTAAAGA 
52 
HA 049-9 
AGAATCCAAATATTCCCAGACACAATCTGGAATGTG
ACTTACACTGGAACAA 
52 
HA 049-10 
GTAGAATGAATCTGAACATGATTTGCTTGTTCCAGT
GTAAGTCACATTCCAG 
52 
HA 049-11 
GCAAATCATGTTCAGATTCATTCTACAGGAACATGA
GATGGCTGACTCAAAG 
52 
HA 049-12 
GAATTCGAGCTCGGTACCCGGCGGCCGCTTTGAGTC
AGCCATCTCATGTTCCT 
53 
 10% Pluronic F68 (Sigma) 
 10 mg/mL BSA (NEB) 
 5X Gibson isothermal buffer [38] 
 10 mM MgCl2 solution (Thermo Fisher Scientific) 
 12.5 mM PEG 8000 (Amersham) 
 2 mM NAD (Sigma) 
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 20 mM DTT (Sigma) 
 T5 exonuclease 10,000 U/mL (NEB) 
 10X buffer 4 (NEB) 
 Taq DNA ligase 40,000 U/mL (NEB) 
 CorrectASE™ (Invitrogen) 
 10X CorrectASE™ Buffer (Invitrogen) 
 Elution buffer (Qiagen) 
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Appendix B: Master Mixes for Microfluidic Assembly and Error Correction Experiments 
The master mixes for assembly and error correction experiments were prepared to 
contain double amounts of reagents.  When the equal size droplets were merged on the 
DMF, the 1X final concentration of reagents was obtained. 
Table 15.  Oligo master mixes. 
Reagent Concentration 
Oligonucleotides 1 µM (Integrated DNA Technologies) 500 nM 100 nM 
Tween 20 (Sigma Aldrich) 0.01% 
Ultra Pure™ DI water (Invitrogen) Add to a final volume 
 
Table 16.  Gibson assembly master mix. 
Reagent Concentration 
T5 Exonuclease 10,000 U/mL (NEB) 0.08 U/µL 
Taq DNA ligase 40,000 U/mL (NEB) 4 U/µL 
Phusion polymerase 2U/µL (Thermo Fisher 
Scientific) 
0.1 U/µL  
Gibson isothermal buffer 2.5X 
Tween 20 (Sigma Aldrich) 0.001% 
Ultra Pure™ DI water (Invitrogen) Add to a final volume 
 
Table 17.  PCR master mixes. 
Reagent Concentration 
5X-HF Phusion detergent-free buffer 
(Thermo Fisher Scientific) 
2.5X 2.5X 2.5X 2.5X 
25 mM of dATP, dGTP, dTTP, dCTP  
(Thermo Fisher Scientific) 
0.5 mM 0.5 mM 0.5 mM 0.5 mM 
Forward and reverse PCR primers 10 
µM each (IDT DNA) 
0.8 µM 0.8 mM 0.8 mM 0.8 mM 
Phusion polymerase 2 U/µL (Thermo 
Fisher Scientific) 
0.2 
U/µL 
0.04 
U/µL 
0.2 
U/µL 
0.04 
U/µL 
50 mM MgCl2 (Thermo Fisher 
Scientific) 
1 mM  1 mM 0 0 
12.5 mM PEG 8000 (Sigma) 1.25 
mM 
1.25 0 0 
Ultra Pure™ DI water (Invitrogen) Add to a final volume 
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Table 18.  Dilution master mix. 
Reagents Concentration 
Tween 20 (Sigma Aldrich) 0.01% 
EB buffer (Qiagen) Add to a final volume 
 
Table 19.  Denature/anneal master mix. 
 
 
 
Table 20.  CorrectASE™ master mix. 
Reagent Concentration 
CorrectASE™ (Invitrogen) 2X 
10X CorrectASE™ buffer (Invitrogen) 5X 
Ultra Pure™ DI water (Invitrogen) Add to a final volume 
 
 
Reagents Concentration 
10X CorrectASE™ buffer (Invitrogen) 5X 
Ultra Pure™ DI water (Invitrogen) Add to a final volume 
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Appendix C:  List of Materials Used to Prepare Samples for Sanger Sequencing 
 Agencourt AMPure XP SPRI magnetic beads (Beckman Coulter) 
 1 Kb Plus DNA ladder (Invitrogen) 
 6X Orange DNA loading dye (Thermo Fisher Scientific) 
 pUC-049 cloning-R reverse primer (IDT DNA) 
5’- CCGGGTACCGAGCTCGAATTCACTG  
 
 pUC-049 cloning-F primers forward primer (ITD DNA) 
5’- GATCCTCTAGAGTCGACCTGCAGGC 
 
 100 pg/µL pUC19 vector (Epicentre) 
 DpnI restriction enzyme 20,000 U/mL (NEB) 
 Phusion polymerase 2 U/µL (Thermo Fisher Scientific) 
 5X-HF Phusion buffer (Thermo Fisher Scientific) 
 Taq DNA ligase 40,000 U/mL (NEB) 
 T5 exonuclease 10,000 U/mL (NEB) 
 5X Isothermal Gibson buffer [38] 
 100 mM dNTPs kit (Thermo Fisher Scientific)  
 Ampicillin (J. Craig Venter Institute) 
 LB agar plates with 100 µg/mL Carbenicillin (Stanford Genome Technology 
 Center)  
 
 LB broth (Teknova) 
 TransforMax EPI300 electrocompetent E. coli cells (Epicentre) 
 pUC19 -5’F 100 µM forward primer (prepared at J. Craig Venter Institute) 
5’- TCCCAGTCACGAC GTTGTAAAACGAC  
 
 pUC19 -3’R 100 µM reverse primer (prepared at J. Craig Venter Institute) 
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5’-ACACAGGAAACAGCTATGACCATGATTACG  
 
 QIAprep spin miniprep kit (Qiagen) 
 Taq DNA polymerase 5 U/µL (Thermo Fisher Scientific) 
 25 mM MgCl2 (Thermo Fisher Scientific) 
 10X Taq buffer with KCl (Thermo Fisher Scientific) 
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Appendix D: Procedures for Cloning of DNA Samples to pUC19 Vector 
Table 21.  Master mix for amplification of pUC19 plasmid DNA. 
  Reagent   Final concentration 
  pUC19 -5’F + pUC19 -3’R primers (10 µM each)   0.4 µM  
  5X-HF Phusion buffer (Thermo Fisher Scientific)    1X  
  dNTPs 25 mM each (Thermo Fisher Scientific)    0.5 mM 
  100 pg/µL pUC19 vector (Epicentre)   0.1 ng/µL  
  Phusion polymerase 2 U/µL (Thermo Fisher Scientific)  0.04 U/µL  
  Ultra Pure™ DI water (Invitrogen)   Up to a final volume 
Thermocycler settings 
Initial denaturation 98 ⁰C – 30 s    
30 cycles:  
Denaturation 98 ⁰C – 10 s  
Annealing/extension 60 ⁰C – 15 s  
Final extension 72 ⁰C – 2 min  
Final extension 72 ⁰C – 5 min   
Assembly of Puc19 and DNA samples 
To perform cloning three reactions were set up: 2.5 µL of the assembly sample were 
combined with 2.5 µL of the vector and 5 µL of 2X CBA; 2.5 µL of the EC1 sample 
were combined with 2.5 µL of the vector and 5 µL of 2X CBA; 2.5 µL of the EC2 
sample were combined with 2.5 µL of the vector and 5 µL of 2X CBA.  
Table 22.  Example of Gibson assembly DNA fragments into pUC19 vector. 
DNA name  Concentration Size   Concentration  
Assembly 7.2 ng/µL 339 bp 32.2 fmol/µL 
EC1  4.7 ng/µL 339 bp  21.0 fmol/µL 
EC2  5 ng/µL 339 bp 22.4 fmol/µL 
pUC19   29.9 ng/µL 2700 bp 17.0 fmol/µL 
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Table 23.  Master mix 2X CBA for cloning. 
Reagent Concentration 
5X isothermal buffer [38] 2.5X 
Phusion polymerase 2 U/µL (Thermo Fisher Scientific) 0.05 U/µL 
Taq DNA ligase 40,000 U/mL (NEB) 4 U/µL 
T5 exonuclease 10,000 U/mL (NEB) 0.08 U/µL 
Ultra Pure™ DI water (Invitrogen) Add to a final volume 
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Appendix E: Procedures for Colony PCR 
A sterile pipette tip was used to touch a single colony.  Then, the tip was inserted in 
PCR tube containing amplification reagents.  The same pipette tip was used to plate the 
colonies on a new LB agar plate with antibiotic selection.  E. coli cells were serving as 
template.  During PCR, the cells were heated to 95 ⁰C to lyse cell walls and released to 
the reaction media.  Thermocycler settings and reagent concentrations are shown in table 
below.  
Thermocycler settings 
Initial denaturation 95 ⁰C – 5 min 
30 cycles: 
Denaturation 95 ⁰C – 15 s 
Annealing 60 ⁰C – 30 s 
Extension 72 ⁰C – 30 s 
Final extension 72 ⁰C – 5 min 
Table 24.  Colony PCR Master Mix. 
Reagent Final concentration 
Taq DNA Polymerase 5 U/µL (Thermo Fisher 
Scientific) 
0.625 U/µL 
25 mM MgCl2 (Thermo Fisher Scientific) 1.56 mM  
10X Taq Buffer with KCl (Thermo Fisher 
Scientific) 
1X 
dNTPs 25 mM each (Thermo Fisher Scientific)  0.625 mM 
Ultra Pure™ DI water (Invitrogen) Add to a final volume 
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Appendix F: Microfluidic Assembly Sanger Sequencing Results 
Table 25.  Sequencing results of 50 nM oligos assembly samples. 
 
Run 1 
(11/10/16) 
Run 2 
(12/6/17) 
Run 3 
(1/4/17) 
Run 4 
(1/18/17) 
Run 5 
(1/20/17) 
Deletion (total) 2 6 12 9 9 
Single-base deletion           
G/C 1 3 5 2 4 
A/T 1 3 7 5 5 
Multiple base deletion 0 0 0 2 0 
Insertion (total)  1 3 1 1 0 
Single-base insertion   0       
G/C 1 1 1 0 0 
A/T 0 0 0 1 0 
Double-base insertion 0 2 0 0 0 
Substitution (total) 1 0 1 0 0 
Transition            
A/T to G/C 0 0 0 0 0 
G/C to A/T 0 0 0 0 0 
Transversion           
G/C to C/G 0 0 0 0 0 
G/C to to T/A 0 0 1 0 0 
A/T to C/G 0 0 0 0 0 
A/T to T/A 1 0 0 0 0 
Number of clones with 
misassemblies 
1 1 0 1 0 
Total errors 4 9 14 10 9 
Number of sequenced 
bases 
3051 2712 3390 3051 3390 
Total without 
misassemblies 
9 8 10 9 10 
Total clones sequenced 10 9 10 10 10 
Overall frequency 
(errors/kb) 
1.31 3.32 4.13 3.28 2.65 
Deletion frequency 
(errors/kb) 
0.66 2.21 3.54 2.95 2.65 
Insertion frequency 
(errors/kb) 
0.33 1.11 0.29 0.33 0 
Substitution frequency 
(errors/kb) 
0.33 0 0.29 0 0 
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Table 26.  Sequencing results of 250 nM oligos assembly samples. 
  
Run 1 
(12/17/15) 
Run 2 
(10/5/16) 
Run3 
(10/24/16) 
Run4 
(11/5/16) 
Run 5 
(11/9/16) 
Deletion (total) 8 7 10 8 6 
Single-base deletion           
G/C 4 3 6 2 3 
A/T 4 3 4 6 3 
Double-base deletion 1 1 0 0 0 
Insertion (total)  0 1 0 1 1 
Single-base insertion           
G/C 0 1 0 1 0 
A/T 0 0 0 0 1 
Double-base insertion 0 0 0 0 0 
Substitution (total) 0 1 1 2 3 
Transition            
A/T to G/C 0 0 0 0 1 
G/C to A/T 0 0 0 1 1 
Transversion           
G/C to C/G 0 1 1 0 0 
AT/ to C/G 0 0 0 1 0 
A/T to T/A 0 0 0 0 1 
Total errors 8 9 11 11 10 
Number of sequenced 
bases 
2712 3390 3390 3051 3051 
Error frequency  
(errors/kb) 
2.95 2.65 3.24 3.61 3.3 
Total clones without 
misassemblies 
8 10 10 9 9 
Number of clones with 
misassemblies 
0 0 0 1 1 
Total clones sequenced 8 10 10 10 10 
Deletion frequency 
(errors/kb) 
2.95 2.06 2.95 2.62 1.97 
Insertion frequency 
(errors/kb) 
0.00 0.29 0.00 0.33 0.33 
Substitution frequency 
(errors/kb) 
0.00 0.29 0.29 0.66 0.98 
 
